FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kadowaki, MAS
   Higasi, PMR
   de Godoy, MO
   de Araujo, EA
   Godoy, AS
   Prade, RA
   Polikarpov, I
AF Seiki Kadowaki, Marco Antonio
   Rabelo Higasi, Paula Miwa
   de Godoy, Mariana Ortiz
   de Araujo, Evandro Ares
   Godoy, Andre Schutzer
   Prade, Rolf Alexander
   Polikarpov, Igor
TI Enzymatic versatility and thermostability of a new aryl-alcohol oxidase
   from Thermothelomyces thermophilus M77
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Aryl-alcohol oxidase; AA3; AAOx; Thermothelomyces thermophilus; X-ray
   structure; Thermostability
ID SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; GMC OXIDOREDUCTASES;
   MYCELIOPHTHORA-THERMOPHILA; ACTIVE-SITE; PROTEINS; DEGRADATION;
   OXIDATION; FUNGI; INVOLVEMENT
AB Background
   Fungal aryl-alcohol oxidases (AAOx) are extracellular flavoenzymes that belong to glucose-methanol-choline oxidoreductase family and are responsible for the selective conversion of primary aromatic alcohols into aldehydes and aromatic aldehydes to their corresponding acids, with concomitant production of hydrogen peroxide (H2O2) as by-product. The H2O2 can be provided to lignin degradation pathway, a biotechnological property explored in biofuel production. In the thermophilic fungus Thermothelomyces thermophilus (formerly Myceliophthora thermophila), just one AAOx was identified in the exo-proteome.
   Methods
   The glycosylated and non-refolded crystal structure of an AAOx from T. thermophilus at 2.6 angstrom resolution was elucidated by X-ray crystallography combined with small-angle X-ray scattering (SAXS) studies. Moreover, biochemical analyses were carried out to shed light on enzyme substrate specificity and thermostability.
   Results
   This flavoenzyme harbors a flavin adenine dinucleotide as a cofactor and is able to oxidize aromatic substrates and 5-HMF. Our results also show that the enzyme has similar oxidation rates for bulky or simple aromatic substrates such as cinnamyl and veratryl alcohols. Moreover, the crystal structure of MtAAOx reveals an open active site, which might explain observed specificity of the enzyme.
   Conclusions
   MtAAOx shows previously undescribed structural differences such as a fully accessible catalytic tunnel, heavy glycosylation and Ca2+ binding site providing evidences for thermostability and activity of the enzymes from AA3_2 subfamily.
   General significance
   Structural and biochemical analyses of MtAAOx could be important for comprehension of aryl-alcohol oxidases structure-function relationships and provide additional molecular tools to be used in future biotechnological applications.
C1 [Seiki Kadowaki, Marco Antonio; Rabelo Higasi, Paula Miwa; de Godoy, Mariana Ortiz; de Araujo, Evandro Ares; Godoy, Andre Schutzer; Polikarpov, Igor] Univ Sao Paulo, Sao Carlos Inst Phys, Av Trabalhador Sao Carlense 400, BR-13566590 Sao Carlos, SP, Brazil.
   [Prade, Rolf Alexander] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.
   [Prade, Rolf Alexander] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.
RP Kadowaki, MAS; Polikarpov, I (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, Av Trabalhador Sao Carlense 400, BR-13566590 Sao Carlos, SP, Brazil.
EM marcokadowaki@gmail.com; ipolikarpov@ifsc.usp.br
RI Godoy, Andre/AAF-2432-2020
OI Godoy, Andre/0000-0002-0613-9164; Kadowaki, Marco
   Antonio/0000-0003-0188-2079
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20505-4,
   2015/13684-0]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPQ)National Council for Scientific and Technological
   Development (CNPq) [405191/2015-4, 440977/2016-9, 303988/2016-9,
   158752/2015-5]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) via grants #2011/20505-4 and #2015/13684-0 and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) via
   grants #405191/2015-4, #440977/2016-9, #303988/2016-9 and
   #158752/2015-5. We are thankful to Dr. Lis S. Miotto for her help with
   initial crystallization assays.
CR Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005
   Alcalde M, 2015, TRENDS BIOTECHNOL, V33, P155, DOI 10.1016/j.tibtech.2014.12.007
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x
   Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]
   Burger VM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29040
   Busk PK, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1625-9
   Carro J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26445-x
   Carro J, 2017, PHYS CHEM CHEM PHYS, V19, P28666, DOI 10.1039/c7cp05904c
   Carro J, 2016, BIOFUEL BIOREFIN TEC, V3, P301, DOI 10.1007/978-3-319-43679-1_12
   Carro J, 2015, FEBS J, V282, P3218, DOI 10.1111/febs.13177
   CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S
   Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708
   Couturier M, 2016, APPL MICROBIOL BIOT, V100, P697, DOI 10.1007/s00253-015-7021-3
   Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398
   Dijkman WP, 2013, APPL MICROBIOL BIOT, V97, P5177, DOI 10.1007/s00253-013-4925-7
   dos Santos HB, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0276-y
   Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   FARMER VC, 1960, BIOCHEM J, V74, P257, DOI 10.1042/bj0740257
   Feldman D, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0244-9
   Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860
   Ferreira P, 2005, BIOCHEM J, V389, P731, DOI 10.1042/BJ20041903
   Ferreira P, 2006, FEBS J, V273, P4878, DOI 10.1111/j.1742-4658.2006.05488.x
   Ferreira P, 2010, BIOCHEM J, V425, P585, DOI 10.1042/BJ20091499
   Ferreira P, 2009, J BIOL CHEM, V284, P24840, DOI 10.1074/jbc.M109.011593
   Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076
   Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gudrun G., 2015, CURR BIOTECHNOL, V4, P100, DOI [DOI 10.2174/2211550104666150423202036, 10.2174/2211550104666150423202036]
   Guillen F, 2000, ARCH BIOCHEM BIOPHYS, V383, P142, DOI 10.1006/abbi.2000.2053
   GUILLEN F, 1992, EUR J BIOCHEM, V209, P603, DOI 10.1111/j.1432-1033.1992.tb17326.x
   Guinier A., 1939, Annales de Physique, V12, P161
   GUTIERREZ A, 1994, APPL ENVIRON MICROB, V60, P1783
   Guttman M, 2013, STRUCTURE, V21, P321, DOI 10.1016/j.str.2013.02.004
   Hammersley AP, 2016, J APPL CRYSTALLOGR, V49, P646, DOI 10.1107/S1600576716000455
   Hernandez-Ortega A, 2012, BIOCHEMISTRY-US, V51, P6595, DOI 10.1021/bi300505z
   Hernandez-Ortega A, 2012, APPL MICROBIOL BIOT, V93, P1395, DOI 10.1007/s00253-011-3836-8
   Hernandez-Ortega A, 2012, CHEMBIOCHEM, V13, P427, DOI 10.1002/cbic.201100709
   Hernandez-Ortega A, 2011, J BIOL CHEM, V286, P41105, DOI 10.1074/jbc.M111.282467
   Hernandez-Ortega A, 2011, BIOCHEM J, V436, P341, DOI 10.1042/BJ20102090
   Jonsson LJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-16
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kadowaki MAS, 2018, FEBS J, V285, P559, DOI 10.1111/febs.14356
   KERSTEN PJ, 1987, J BACTERIOL, V169, P2195, DOI 10.1128/jb.169.5.2195-2201.1987
   Kolbusz MA, 2014, FUNGAL GENET BIOL, V72, P10, DOI 10.1016/j.fgb.2014.05.006
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Macheroux P, 1999, METH MOL B, V131, P1
   Makela MR, 2015, ADV APPL MICROBIOL, V91, P63, DOI 10.1016/bs.aambs.2014.12.001
   Mann-Felix Y, 2015, MYCOLOGIA, V107, P619, DOI [10.3852/14-288, 10.3852/14-228]
   Mathieu Y, 2016, APPL ENVIRON MICROB, V82, P2411, DOI 10.1128/AEM.03761-15
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   McKenna SM, 2015, GREEN CHEM, V17, P3271, DOI 10.1039/c5gc00707k
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Pardo-Planas O, 2017, BIORESOURCE TECHNOL, V243, P874, DOI 10.1016/j.biortech.2017.06.183
   Pardo-Planas O, 2017, J IND MICROBIOL BIOT, V44, P247, DOI 10.1007/s10295-016-1884-x
   Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528
   Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638
   Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901
   Romero E, 2009, BBA-PROTEINS PROTEOM, V1794, P689, DOI 10.1016/j.bbapap.2008.11.013
   Ruiz-Duenas FJ, 2006, PROTEIN EXPRES PURIF, V45, P191, DOI 10.1016/j.pep.2005.06.003
   Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461
   Segato F, 2012, ENZYME MICROB TECH, V51, P100, DOI 10.1016/j.enzmictec.2012.04.008
   Serrano A, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1555-z
   Singh B, 2016, CRIT REV BIOTECHNOL, V36, P59, DOI 10.3109/07388551.2014.923985
   Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79
   Sutzl L, 2018, APPL MICROBIOL BIOT, V102, P2477, DOI 10.1007/s00253-018-8784-0
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Tamaru Y, 2018, BIOTECHNOL LETT, V40, P1077, DOI 10.1007/s10529-018-2534-3
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Varela E, 2000, BBA-PROTEIN STRUCT M, V1476, P129, DOI 10.1016/S0167-4838(99)00227-7
   Vina-Gonzalez J, 2018, BIOTECHNOL BIOENG, V115, P1666, DOI 10.1002/bit.26585
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109
   Xie CL, 2016, ELECTROPHORESIS, V37, P310, DOI 10.1002/elps.201500312
   Zamocky M, 2004, GENE, V338, P1, DOI 10.1016/j.gene.2004.04.025
   Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172
NR 84
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD OCT
PY 2020
VL 1864
IS 10
AR 129681
DI 10.1016/j.bbagen.2020.129681
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA MQ2EB
UT WOS:000552708800010
PM 32653619
DA 2020-11-24
ER

PT J
AU Puhl, AC
   Bogart, JW
   Haberman, VA
   Larson, JE
   Godoy, AS
   Norris-Drouin, JL
   Cholensky, SH
   Leisner, TM
   Frye, SV
   Parise, LV
   Bowers, AA
   Pearce, KH
AF Puhl, Ana C.
   Bogart, Jonathan W.
   Haberman, Victoria A.
   Larson, Jacob E.
   Godoy, Andre S.
   Norris-Drouin, Jacqueline L.
   Cholensky, Stephanie H.
   Leisner, Tina M.
   Frye, Stephen, V
   Parise, Leslie, V
   Bowers, Albert A.
   Pearce, Kenneth H.
TI Discovery and Characterization of Peptide Inhibitors for Calcium and
   Integrin Binding Protein 1
SO ACS CHEMICAL BIOLOGY
LA English
DT Article
ID NEGATIVE BREAST-CANCER; CYTOPLASMIC DOMAIN; STAPLED PEPTIDES;
   DNA-BINDING; IN-VITRO; CIB1; IDENTIFICATION; PATHWAYS; ALPHA-IIB-BETA-3;
   ACTIVATION
AB Calcium and integrin binding protein 1 (CIB1) is an EF-hand-containing, small intracellular protein that has recently been implicated in cancer cell survival and proliferation. In particular, CIB1 depletion significantly impairs tumor growth in triple-negative breast cancer (TNBC). Thus, CIB1 is a potentially attractive target for cancer chemotherapy that has yet to be validated by a chemical probe. To produce a probe molecule to the CIB1 helix 10 (H10) pocket and demonstrate that it is a viable target for molecular intervention, we employed random peptide phage display to screen and select CIB1-binding peptides. The top peptide sequence selected, UNC10245092, was produced synthetically, and binding to CIB1 was confirmed by isothermal titration calorimetry (ITC) and a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. Both assays showed that the peptide bound to CIBI with low nanomolar affinity. CIB1 was cocrystallized with UNC10245092, and the 2.1 angstrom resolution structure revealed that the peptide binds as an alpha-helix in the H10 pocket, displacing the CIBI C-terminal H10 helix and causing conformational changes in H7 and H8. UNC10245092 was further derivatized with a C-terminal Tat-derived cell penetrating peptide (CPP) to demonstrate its effects on TNBC cells in culture, which are consistent with results of CIB1 depletion. These studies provide a first-in-class chemical tool for CIB1 inhibition in cell culture and validate the CIB1 H10 pocket for future probe and drug discovery efforts.
C1 [Puhl, Ana C.; Bogart, Jonathan W.; Haberman, Victoria A.; Larson, Jacob E.; Norris-Drouin, Jacqueline L.; Cholensky, Stephanie H.; Frye, Stephen, V; Bowers, Albert A.; Pearce, Kenneth H.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Eshelman Sch Pharm, Chem Biol & Med Chem, Chapel Hill, NC 27599 USA.
   [Frye, Stephen, V; Parise, Leslie, V; Bowers, Albert A.; Pearce, Kenneth H.] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.
   [Bowers, Albert A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
   [Godoy, Andre S.] Univ Sao Paulo, Inst Phys Sao Carlos, BR-13563120 Sao Carlos, Brazil.
   [Leisner, Tina M.; Parise, Leslie, V] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.
RP Bowers, AA; Pearce, KH (corresponding author), Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Eshelman Sch Pharm, Chem Biol & Med Chem, Chapel Hill, NC 27599 USA.; Bowers, AA; Pearce, KH (corresponding author), UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Bowers, AA (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
EM abower2@email.unc.edu; khpearce@unc.edu
RI Godoy, Andre/I-1302-2017
OI Godoy, Andre/0000-0002-0613-9164
FU NIDDKUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [NIH 1R01DK103746, NIH
   1R01DK101645]; NIGMSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [NIH 1R35GM125005]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [NIH 1R01GM133107]; North Carolina Biotech Center (NCBC)
   [2017-BIG-6515]; Sao Paulo Research Foundation, FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/19712-9]
FX We thank the UNC Lineberger Comprehensive Cancer Center for general
   support of facilities and resources. A.C.P. and K.H.P. were supported in
   part by grants from the NIDDK (NIH 1R01DK103746 and NIH 1R01DK101645).
   A.A.B., J.W.B., and V.A.H. were supported in whole or in part by a grant
   from the NIGMS (NIH 1R35GM125005). L.V.P and T.M.L. are supported by
   grants from the NIH (NIH 1R01GM133107) and North Carolina Biotech Center
   (NCBC, 2017-BIG-6515). A.S.G. is supported by Sao Paulo Research
   Foundation, FAPESP (2016/19712-9).
CR Ali AM, 2019, COMPUT STRUCT BIOTEC, V17, P263, DOI 10.1016/j.csbj.2019.01.012
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200
   Black JL, 2015, BREAST CANCER RES TR, V152, P337, DOI 10.1007/s10549-015-3458-4
   Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Chung AH, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0740-2
   De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361
   Deng SJ, 2004, J VIROL, V78, P2637, DOI 10.1128/JVI.78.5.2637-2641.2003
   Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Freeman TC, 2013, BIOCHEMISTRY-US, V52, P7082, DOI 10.1021/bi400678y
   Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200
   Gordon V, 2013, CLIN CANCER RES, V19, P3738, DOI 10.1158/1078-0432.CCR-12-0274
   GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5
   Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317
   Hollenbach AD, 2002, BBA-GENE STRUCT EXPR, V1574, P321, DOI 10.1016/S0167-4781(02)00230-0
   Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306
   Huang H, 2011, J BIOL CHEM, V286, P17181, DOI 10.1074/jbc.M110.179028
   Hwang PM, 2000, J MOL RECOGNIT, V13, P83, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<83::AID-JMR491>3.0.CO;2-A
   Iannone MA, 2004, MOL ENDOCRINOL, V18, P1064, DOI 10.1210/me.2003-0432
   Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Lee A, 2018, CANCER TREAT REV, V62, P110, DOI 10.1016/j.ctrv.2017.11.003
   Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014
   Leisner TM, 2013, ONCOGENE, V32, P4017, DOI 10.1038/onc.2012.408
   Leisner TM, 2016, FASEB J, V30, P2640, DOI 10.1096/fj.201500073R
   Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389
   Moiola M, 2019, MOLECULES, V24, DOI 10.3390/molecules24203654
   Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836
   Naik MU, 2011, INT J CANCER, V128, P587, DOI 10.1002/ijc.25388
   Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pearce KH, 1997, J BIOL CHEM, V272, P20595, DOI 10.1074/jbc.272.33.20595
   Poillot C, 2012, J BIOL CHEM, V287, P17331, DOI 10.1074/jbc.M112.360628
   Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10
   Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381
   Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058
   Sobczak A, 2005, ACTA BIOCHIM POL, V52, P469
   Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X
   Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701
   Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200
   Yamniuk AP, 2005, PROTEIN SCI, V14, P1429, DOI 10.1110/ps.041312805
   Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b
   Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106
   Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131
   Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5
NR 50
TC 1
Z9 1
U1 7
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
EI 1554-8937
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD JUN 19
PY 2020
VL 15
IS 6
BP 1505
EP 1516
DI 10.1021/acschembio.0c00144
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA MD0JD
UT WOS:000543662300025
PM 32383857
OA Green Accepted
DA 2020-11-24
ER

PT J
AU Fernandes, RS
   Freire, MCLC
   Bueno, RV
   Godoy, AS
   Gil, LHVG
   Oliva, G
AF Fernandes, Rafaela S.
   Freire, Marjorie C. L. C.
   Bueno, Renata, V
   Godoy, Andre S.
   Gil, Laura H. V. G.
   Oliva, Glaucius
TI Reporter Replicons for Antiviral Drug Discovery against Positive
   Single-Stranded RNA Viruses
SO VIRUSES-BASEL
LA English
DT Review
DE replicon systems; (+) ssRNA viruses; direct-acting antivirals; drug
   discovery
ID HEPATITIS-C VIRUS; ACUTE RESPIRATORY SYNDROME; GREEN FLUORESCENT
   PROTEIN; SMALL-MOLECULE INHIBITORS; SARS-CORONAVIRUS REPLICON;
   SERINE-TYPE PROTEINASE; CELL-LINE; REPLICATION INHIBITOR; EXPRESSING
   REPLICON; DENGUE VIRUS
AB Single-stranded positive RNA ((+) ssRNA) viruses include several important human pathogens. Some members are responsible for large outbreaks, such as Zika virus, West Nile virus, SARS-CoV, and SARS-CoV-2, while others are endemic, causing an enormous global health burden. Since vaccines or specific treatments are not available for most viral infections, the discovery of direct-acting antivirals (DAA) is an urgent need. Still, the low-throughput nature of and biosafety concerns related to traditional antiviral assays hinders the discovery of new inhibitors. With the advances of reverse genetics, reporter replicon systems have become an alternative tool for the screening of DAAs. Herein, we review decades of the use of (+) ssRNA viruses replicon systems for the discovery of antiviral agents. We summarize different strategies used to develop those systems, as well as highlight some of the most promising inhibitors identified by the method. Despite the genetic alterations introduced, reporter replicons have been shown to be reliable systems for screening and identification of viral replication inhibitors and, therefore, an important tool for the discovery of new DAAs.
C1 [Fernandes, Rafaela S.; Freire, Marjorie C. L. C.; Bueno, Renata, V; Godoy, Andre S.; Oliva, Glaucius] Univ Sao Paulo, Phys Inst Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil.
   [Gil, Laura H. V. G.] IAM FIOCRUZ, Inst Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
RP Oliva, G (corresponding author), Univ Sao Paulo, Phys Inst Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil.
EM rafaela.fernandes@usp.br; marjorie_freire_@hotmail.com;
   buenorvieira@gmail.com; andre_godoy@yahoo.com.br; lgilfiocruz@gmail.com;
   oliva@ifsc.usp.br
RI Oliva, Glaucius/J-2382-2015; Godoy, Andre/I-1302-2017
OI Oliva, Glaucius/0000-0003-2719-0302; Godoy, Andre/0000-0002-0613-9164;
   Freire, Marjorie/0000-0001-7734-5144
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP-CEPID)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2013/07600-3, 2018/05130-3, 2018/17095-8, 2016/19712-9];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [400773/2019-8, 151058/2018-0]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP-CEPID grant 2013/07600-3 and grants 2018/05130-3,
   2018/17095-8, and 2016/19712-9) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-grants 400773/2019-8 and 151058/2018-0).
CR Adedeji AO, 2014, ANTIMICROB AGENTS CH, V58, P4894, DOI 10.1128/AAC.02994-14
   Adedeji AO, 2012, ANTIMICROB AGENTS CH, V56, P4718, DOI 10.1128/AAC.00957-12
   Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013
   Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06
   Alqahtani S.A., 2009, HCV JOURNEY DISCOVER, P223, DOI [10.1007/7355_2018_59, DOI 10.1007/7355_2018_59]
   Amblard F, 2018, BIOORG MED CHEM LETT, V28, P2165, DOI 10.1016/j.bmcl.2018.05.012
   Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Balasubramanian A, 2016, ANTIVIR RES, V134, P6, DOI 10.1016/j.antiviral.2016.08.014
   BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993
   BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995
   BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995
   BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994
   Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358
   Bok K, 2008, VIROLOGY, V380, P328, DOI 10.1016/j.virol.2008.08.007
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902
   Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07
   Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006
   Cucinotta D, 2020, ACTA BIOMED, V91, P157, DOI [10.23750/abm.v91i1.9397, DOI 10.23750/ABM.V91I1.9397]
   De Palma AM, 2008, MED RES REV, V28, P823, DOI 10.1002/med.20125
   De Palma AM, 2008, J VIROL, V82, P4720, DOI 10.1128/JVI.01338-07
   Delang L, 2013, CURR TOP MICROBIOL, V369, P289, DOI 10.1007/978-3-642-27340-7_12
   Dou D, 2012, BIOORGAN MED CHEM, V20, P2111, DOI 10.1016/j.bmc.2012.01.030
   FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960
   Gao QQ, 2015, ANTIMICROB AGENTS CH, V59, P2654, DOI 10.1128/AAC.05108-14
   Ge F, 2008, ANTIVIR RES, V80, P107, DOI 10.1016/j.antiviral.2008.05.005
   Ge F, 2007, VIROLOGY, V360, P150, DOI 10.1016/j.virol.2006.10.016
   GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993
   Green N, 2008, EXPERT OPIN DRUG DIS, V3, P671, DOI 10.1517/17460441.3.6.671
   Harmalkar DS, 2019, EUR J MED CHEM, V184, DOI 10.1016/j.ejmech.2019.111733
   Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015
   Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2
   Horscroft Nigel, 2005, Antiviral Chemistry & Chemotherapy, V16, P1
   Hsu YC, 2012, ARCH VIROL, V157, P681, DOI 10.1007/s00705-012-1224-z
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huber SA, 1999, ADV VIRUS RES, V51, P35
   Johne R, 2014, INFECT GENET EVOL, V27, P212, DOI 10.1016/j.meegid.2014.06.024
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Kanda T, 2005, BIOCHEM BIOPH RES CO, V331, P621, DOI 10.1016/j.bbrc.2005.03.212
   Kim C, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0557-8
   Kim TK, 2010, ANAL BIOANAL CHEM, V397, P3173, DOI 10.1007/s00216-010-3821-6
   Kummerer BM, 2018, ADV EXP MED BIOL, V1062, P165, DOI 10.1007/978-981-10-8727-1_12
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099
   Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009
   Lani R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11421
   Leardkamolkarn V, 2012, J BIOMOL SCREEN, V17, P283, DOI 10.1177/1087057111426903
   Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200
   LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995
   Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006
   Lindenbach B.D., 2007, FIELDS VIROLOGY, P1101, DOI DOI 10.1016/0038-092X(88)90131-4
   Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001
   Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110
   Lohmann V, 2019, MED MICROBIOL IMMUN, V208, P3, DOI 10.1007/s00430-018-0566-x
   Lu LJ, 2004, ANTIMICROB AGENTS CH, V48, P2260, DOI 10.1128/AAC.48.6.2260-2266.2004
   Lucero Y, 2018, VACCINE, V36, P5435, DOI 10.1016/j.vaccine.2017.06.043
   Luna JM, 2019, CURR OPIN VIROL, V35, P27, DOI 10.1016/j.coviro.2019.02.008
   Malik YS, 2020, VET QUART, V40, P68, DOI 10.1080/01652176.2020.1727993
   Mandadapu SR, 2013, BIOORG MED CHEM LETT, V23, P5941, DOI 10.1016/j.bmcl.2013.08.073
   McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847
   Mello C, 2014, ANTIMICROB AGENTS CH, V58, P1546, DOI 10.1128/AAC.01746-13
   Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/ERV.12.6, 10.1586/erv.12.6]
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   Morrey JD, 2002, ANTIVIR RES, V55, P107, DOI 10.1016/S0166-3542(02)00013-X
   Mueller NH, 2008, ANTIMICROB AGENTS CH, V52, P3385, DOI 10.1128/AAC.01508-07
   Nelemans T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100961
   Netzler NE, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00003-19
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Nimgaonkar I, 2018, NAT REV GASTRO HEPAT, V15, P96, DOI 10.1038/nrgastro.2017.150
   Nishiyama T, 2019, J VIROL METHODS, V270, P1, DOI 10.1016/j.jviromet.2019.04.017
   Norder H, 2011, ANTIVIR RES, V89, P204, DOI 10.1016/j.antiviral.2010.12.007
   O'Boyle DR, 2005, ANTIMICROB AGENTS CH, V49, P1346, DOI 10.1128/AAC.49.4.1346-1353.2005
   Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557
   Patkar CG, 2009, ANTIMICROB AGENTS CH, V53, P4103, DOI 10.1128/AAC.00074-09
   Payne S, 2017, VIRUSES: FROM UNDERSTANDING TO INVESTIGATION, P115, DOI 10.1016/B978-0-12-803109-4.00012-X
   Payne S, 2017, VIRUSES: FROM UNDERSTANDING TO INVESTIGATION, P121, DOI 10.1016/B978-0-12-803109-4.00013-1
   Payne S, 2017, VIRUSES: FROM UNDERSTANDING TO INVESTIGATION, P149, DOI 10.1016/B978-0-12-803109-4.00017-9
   Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824
   Pietla MK, 2017, VIRUS RES, V234, P44, DOI 10.1016/j.virusres.2017.01.007
   Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923
   Puig-Basagoiti F, 2006, ANTIMICROB AGENTS CH, V50, P1320, DOI 10.1128/AAC.50.4.1320-1329.2006
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002
   Rocha-Pereira J, 2014, BIOCHEM PHARMACOL, V91, P1, DOI 10.1016/j.bcp.2014.05.021
   Romero-Brey I, 2015, MBIO, V6, DOI 10.1128/mBio.00759-15
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shi PY, 2002, VIROLOGY, V296, P219, DOI 10.1006/viro.2002.1453
   Shimizu H, 2014, LANCET INFECT DIS, V14, P262, DOI 10.1016/S1473-3099(13)70330-X
   Siltz LAF, 2014, J VIROL, V88, P11091, DOI 10.1128/JVI.01877-14
   Sofia M.J., 2019, HCV JOURNEY DISCOVER, P223
   Stuyver Lieven J., 2006, Antiviral Chemistry & Chemotherapy, V17, P79
   Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0
   Teshale EH, 2010, EMERG INFECT DIS, V16, P126, DOI 10.3201/eid1601.090764
   Tews BA, 2017, METHODS MOL BIOL, V1499, P15, DOI 10.1007/978-1-4939-6481-9_2
   TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993
   Tulloch F, 2014, J VIROL METHODS, V209, P35, DOI 10.1016/j.jviromet.2014.08.020
   van der Linden L, 2010, J VIROL, V84, P7535, DOI 10.1128/JVI.02684-09
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Wada Y, 2017, VIROLOGY, V505, P102, DOI 10.1016/j.virol.2017.02.014
   Wang JM, 2008, BIOCHEM BIOPH RES CO, V374, P138, DOI 10.1016/j.bbrc.2008.06.129
   Wehbe M, 2016, J VIROL METHODS, V230, P1, DOI 10.1016/j.jviromet.2016.01.005
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   World Health Organization, 2018, GUID CAR TREATM PERS
   Wu KX, 2017, ANTIVIR RES, V143, P122, DOI 10.1016/j.antiviral.2017.04.008
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xiong Q, 2017, J VIROL METHODS, V248, P87, DOI 10.1016/j.jviromet.2017.06.009
   Xu L, 2014, VIRUSES-BASEL, V6, P2778, DOI 10.3390/v6072778
   Yang LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-212
   Zhang QY, 2017, ARCH VIROL, V162, P3417, DOI 10.1007/s00705-017-3508-9
NR 116
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2020
VL 12
IS 6
AR 598
DI 10.3390/v12060598
PG 22
WC Virology
SC Virology
GA MR9NP
UT WOS:000553916300001
PM 32486283
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Noske, GD
   Gawriljuk, VO
   Fernandes, RS
   Furtado, ND
   Bonaldo, MC
   Oliva, G
   Godoy, AS
AF Noske, Gabriela Dias
   Gawriljuk, Victor Oliveira
   Fernandes, Rafaela Sachetto
   Furtado, Nathalia Dias
   Bonaldo, Myrna Cristina
   Oliva, Glaucius
   Godoy, Andre Schutzer
TI Structural characterization and polymorphism analysis of the NS2B-NS3
   protease from the 2017 Brazilian circulating strain of Yellow Fever
   virus
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Yellow Fever virus; Flavivirus; Protease; NS3; NS2B
ID DENGUE VIRUS; ZIKA VIRUS; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE;
   HELICASE; MODEL; INHIBITION; ACTIVATION; FEATURES; COMPLEX
AB Background: The Yellow Fever virus (YFV) is transmitted by mosquitos and causes an infection with symptoms including fever, headaches and nausea. In 20-50% of the cases, the disease may evolve to a visceral stage, reaching high mortality rates. YFV NS2B-NS3 protease has been identified as an important drug target.
   Methods: Herein, we describe the crystal structure of the NS2B-NS3 protease from the 2017 YFV Brazilian circulating strain using X-ray crystallography. Furthermore, we used a combination of biochemical and biophysical assays to characterize the enzyme and investigate the impact of the polymorphisms observed in different YFV circulating strains.
   Results: Surprisingly, the crystal structure of YFV protease seems to adopt the closed conformation without the presence of a binding partner. Although D88E and K121R mutants exhibited a lower affinity for the substrate, both revealed to be more processive, resulting in a similar catalytic efficiency in relation to the WT protease. Still, both mutants showed an accentuated decrease in stability when compared with the WT.
   Conclusions: The crystal structure of YFV NS2B-NS3 in closed conformation might be an important tool for the development of new drugs, as well as understanding the activation mechanism of viral proteases. Biochemical analyses indicate that the NS2B-NS3 protease of the circulating strain of YFV is more stable than previous strains.
   General significance: The YFV NS2B-NS3 protease is the first flaviviral structure described in its closed conformation when in a free form, implying that external factors might induce the activation of the enzyme.
C1 [Noske, Gabriela Dias; Gawriljuk, Victor Oliveira; Fernandes, Rafaela Sachetto; Oliva, Glaucius; Godoy, Andre Schutzer] Univ Sao Paulo, Phys Inst Sao Carlos, Av Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, Brazil.
   [Furtado, Nathalia Dias; Bonaldo, Myrna Cristina] Fundacao Osvaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol & Flavivirus, Rio De Janeiro, Brazil.
RP Godoy, AS (corresponding author), Univ Sao Paulo, Phys Inst Sao Carlos, Av Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, Brazil.
EM andregodoy@ifsc.usp.br
RI Godoy, Andre/AAF-2432-2020
OI Godoy, Andre/0000-0002-0613-9164
FU Sao Paulo Research Foundation - FAPESP (CEPID)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07600-3, 2016/19712-9,
   2018/05130-3]; Diamond Light Source for beamtime [mx22129]; Preventing
   and Combating the Zika Virus; MCTIC/FNDCT- CNPq/MEC-CAPES/MS-Decit
   [426767/2018-7, 88881.130684/2016-01]; INOVA-Fiocruz [VPPIS-004-FIO18]
FX The authors would like to thank the funding from the Sao Paulo Research
   Foundation - FAPESP (CEPID grant #2013/07600-3 and post-doctoral grants
   2016/19712-9 and 2018/05130-3). The authors would like to thank Diamond
   Light Source for beamtime (proposal mx22129), and the staff of beamline
   124 for support. Part of this study is funded by grants from Preventing
   and Combating the Zika Virus, MCTIC/FNDCT- CNPq/MEC-CAPES/MS-Decit
   (Grants 426767/2018-7 and 88881.130684/2016-01) and INOVA-Fiocruz (Grant
   VPPIS-004-FIO18).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Carpp LN, 2011, MICROBES INFECT, V13, P85, DOI 10.1016/j.micinf.2010.10.010
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   de Godoy AS, 2019, CURR OPIN STRUC BIOL, V59, P65, DOI 10.1016/j.sbi.2019.02.014
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015
   Hill ME, 2019, BIOCHEMISTRY-US, V58, P776, DOI 10.1021/acs.biochem.8b00978
   Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003
   Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li HD, 2019, NEURON, V101, P1089, DOI 10.1016/j.neuron.2019.01.010
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   McGuinness I, 2017, NEUROHOSPITALIST, V7, P157, DOI 10.1177/1941874417708129
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/ERV.12.6, 10.1586/erv.12.6]
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Paules C.I., 2017, NEW ENGL J MED, V376, DOI [10.1056/NEJMpl 702172, DOI 10.1056/NEJMPL702172]
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319
   Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X
   Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
NR 55
TC 2
Z9 2
U1 2
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD APR
PY 2020
VL 1864
IS 4
AR 129521
DI 10.1016/j.bbagen.2020.129521
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KT0FI
UT WOS:000518686000009
PM 31931019
DA 2020-11-24
ER

PT J
AU Sonoda, MT
   Godoy, AS
   Pellegrini, VOA
   Kadowaki, MAS
   Nascimento, AS
   Polikarpov, I
AF Sonoda, Milton T.
   Godoy, Andre S.
   Pellegrini, Vanessa O. A.
   Kadowaki, Marco A. S.
   Nascimento, Alessandro S.
   Polikarpov, Igor
TI Structure and dynamics of Trichoderma harzianum Cel7B suggest molecular
   architecture adaptations required for a wide spectrum of activities on
   plant cell wall polysaccharides
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Trichoderma harzianum; GH7; Cellulase; Protein crystallography;
   Molecular dynamics simulations
ID HYDROGEN-BONDING SYSTEM; ENDOGLUCANASE I CEL7B; SYNCHROTRON X-RAY;
   CRYSTAL-STRUCTURE; CELLOBIOHYDROLASE-I; HUMICOLA-INSOLENS; ANGSTROM
   RESOLUTION; CATALYTIC CORE; FORCE-FIELD; ENZYMES
AB Cellulases from glycoside hydrolase family 7 (GH7) play crucial roles in plant lignocellulose deconstruction by fungi, but structural information available for GH7 fungal endoglucanases is limited when compared to the number of known sequences in the family. Here, we report the X-ray structure of the glycosylated catalytic domain (CD) of Trichoderma harzianwn endoglucanase, ThCel7B, solved and refined at 2.9 angstrom resolution. Additionally, our extensive molecular dynamics simulations of this enzyme in complex with a variety of oligosaccharides provide a better understanding of its promiscuous hydrolytic activities on plant cell wall polysaccharides. The simulations demonstrate the importance of the hydrogen bond between substrate O2 hydroxyl in the subsite - 1 and a side chain of catalytic Glu196 which renders ThCel7B capable to catalytically cleave cello and xylooligosaccharides, but not mannooligosaccharides. Moreover, detailed structural analyses and MD simulations revealed an additional binding pocket, suitable for accommodation of oligosaccharide decorations and/or substrates with mixed glycoside bonds that abuts onto the binding cleft close to subsite +2.
C1 [Sonoda, Milton T.] Univ Fed Triangulo Mineiro, Inst Ciencias Exatas Nat & Educ, Dept Fis, Ave Frei Paulino,30, BR-38025180 Bairro Abadia Uberaba, MG, Brazil.
   [Godoy, Andre S.; Pellegrini, Vanessa O. A.; Kadowaki, Marco A. S.; Nascimento, Alessandro S.; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Ave Trabalhador Saocarlense,400, BR-13566590 Sao Carlos, SP, Brazil.
RP Nascimento, AS; Polikarpov, I (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Ave Trabalhador Saocarlense,400, BR-13566590 Sao Carlos, SP, Brazil.
EM asnascimento@ifsc.usp.br; ipolikarpov@ifsc.usp.br
RI Nascimento, Alessandro/Y-3394-2019; Godoy, Andre/AAF-2432-2020
OI Nascimento, Alessandro/0000-0001-6656-5379; Godoy,
   Andre/0000-0002-0613-9164; Kadowaki, Marco Antonio/0000-0003-0188-2079
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/13684-0,
   2014/06565-2, 2017/18173-0]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq) [405191/2015-4, 140667/2015-6,
   158752/2015-5, 303988/2016-9, 440977/2016-9]; Brazilian agency
   CAPESCAPES [A061_2013, 001]
FX We would like to acknowledge support of the Brazilian funding agencies
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) via grants
   #2015/13684-0, 2015/13684-0, 2014/06565-2 and 2017/18173-0; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) via grants
   #405191/2015-4, 140667/2015-6, 158752/2015-5, 303988/2016-9 and
   440977/2016-9. We also would like to thank Brazilian agency CAPES for
   support via grant A061_2013 and 001.
CR Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   ANTHONY R, 1993, CURR OPIN BIOTECH, V4, P469
   Ardevol A, 2015, J AM CHEM SOC, V137, P7528, DOI 10.1021/jacs.5b01156
   Barnett CB, 2011, J AM CHEM SOC, V133, P19474, DOI 10.1021/ja206842j
   Barnett CB, 2010, J AM CHEM SOC, V132, P12800, DOI 10.1021/ja103766w
   Bischof RH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0507-6
   Bu LT, 2013, J BIOL CHEM, V288, P12175, DOI 10.1074/jbc.M113.462465
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5
   Crucello A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122122
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765
   Davies GJ, 1997, J BIOTECHNOL, V57, P91, DOI 10.1016/S0168-1656(97)00092-8
   Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523
   Davies GJ, 1996, ACTA CRYSTALLOGR D, V52, P7, DOI 10.1107/S0907444995009280
   de Castro AM, 2010, APPL BIOCHEM BIOTECH, V162, P1612, DOI [10.1007/s12010-010-8986-0, 10.1007/s12010-010-8942-z]
   DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495
   Ducros VMA, 2003, CHEM BIOL, V10, P619, DOI 10.1016/S1074-5521(03)00143-1
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Fernandez MD, 2005, J AM CHEM SOC, V127, P7379, DOI 10.1021/ja051020+
   Florindo RN, 2018, NEW BIOTECHNOL, V40, P218, DOI 10.1016/j.nbt.2017.08.012
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   KALSNER I, 1995, GLYCOCONJUGATE J, V12, P360, DOI 10.1007/BF00731339
   Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571
   Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820
   Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243
   Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Li JH, 2010, J PHYS CHEM B, V114, P15261, DOI 10.1021/jp1064177
   Lima LHF, 2013, CELLULOSE, V20, P1573, DOI 10.1007/s10570-013-9933-3
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d
   Mackenzie LF, 1998, BIOCHEM J, V335, P409, DOI 10.1042/bj3350409
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319
   Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w
   Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c
   Pellegrini VOA, 2015, APPL MICROBIOL BIOT, V99, P9591, DOI 10.1007/s00253-015-6772-1
   Pena MJ, 2012, METHOD ENZYMOL, V510, P121, DOI 10.1016/B978-0-12-415931-0.00007-0
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Storms R, 2005, PLASMID, V53, P191, DOI 10.1016/j.plasmid.2004.10.001
   Sulzenbacher G, 1997, BIOCHEMISTRY-US, V36, P5902, DOI 10.1021/bi962963+
   Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h
   Umemura M, 2004, J PHYS CHEM A, V108, P7063, DOI 10.1021/jp049044a
   Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057
   Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010
   Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063
   Yakovlev I, 2012, APPL MICROBIOL BIOT, V95, P979, DOI 10.1007/s00253-012-4206-x
   Zwart P. H., 2005, CCP4 NEWSLETTER, V43, P27
   1987, GENE, V61, P155, DOI DOI 10.1016/0378-1119(87)90110-7
   1953, BIOL REV, V28, P416, DOI DOI 10.1111/J.1469-185X.1953.TB01386.X
NR 63
TC 1
Z9 1
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JUN
PY 2019
VL 1863
IS 6
BP 1015
EP 1026
DI 10.1016/j.bbagen.2019.03.013
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA HY1PD
UT WOS:000467888000003
PM 30898558
DA 2020-11-24
ER

PT J
AU Nakamura, AM
   Kadowaki, MAS
   Godoy, A
   Nascimento, AS
   Polikarpov, I
AF Nakamura, Aline M.
   Seiki Kadowaki, Marco Antonio
   Godoy, Andre
   Nascimento, Alessandro S.
   Polikarpov, Igor
TI Low-resolution envelope, biophysical analysis and biochemical
   characterization of a short-chain specific and halotolerant
   carboxylesterase from Bacillus licheniformis
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE alpha/beta hydrolase; Carboxylesterases; Bacillus licheniformis
ID LIGATION-INDEPENDENT CLONING; COMPLETE GENOME SEQUENCE; HYDROLASE FOLD
   ENZYMES; ALPHA/BETA-HYDROLASE; INTERFACIAL ACTIVATION;
   PSEUDOMONAS-FLUORESCENS; MONOACYLGLYCEROL LIPASE; TOLERANT ESTERASE;
   MOLECULAR-CLONING; CRYSTAL-STRUCTURE
AB Esterases are widely applied in industrial processes due to their versatility, regio- and enantioselectivity, lack of cofactors and stability in organic solvents. Bacillus licheniformis, a microorganism frequently used in industrial and biotechnological applications such as dairy, baking, beverage, pulp and paper, detergent and cosmetics production, organic synthesis and waste management, is a promising source of esterases. Here we describe the biochemical and biophysical characterization of B. licheniformis carboxylesterase BlEst1 and its SAXS-derived molecular envelope. BlEst1 has optimal hydrolytic activity against p-nitrophenyl acetate at pH 7.0 and 40 degrees C. Furthermore, BlEst1 is stable in different organic solvents such as methanol, isopropanol and butanol. The BlEst1 homology model reveals a typical alpha/beta hydrolase core with an adjacent auxiliary domain, snuggly fitting the experimental low-resolution SAXS molecular envelope. Moreover, BlEst1 maintained considerable part of its activity in the presence of up to 5 M NaCl and its thermal stability was significantly enhanced by the presence of salt, revealing its halotolerant character. The ability to work under harsh conditions makes BlEst1 an interesting candidate for industrial applications. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Nakamura, Aline M.; Seiki Kadowaki, Marco Antonio; Godoy, Andre; Nascimento, Alessandro S.; Polikarpov, Igor] Univ Sao Paulo, Sao Carlos Inst Phys, Av Trabalhador Sao Carlense 400, BR-13566590 Sao Carlos, SP, Brazil.
RP Polikarpov, I (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, Av Trabalhador Sao Carlense 400, BR-13566590 Sao Carlos, SP, Brazil.
EM asnascimento@ifsc.usp.br; ipolikarpov@ifsc.usp.br
RI Nascimento, Alessandro/Y-3394-2019; Godoy, Andre/AAF-2432-2020
OI Nascimento, Alessandro/0000-0001-6656-5379; Godoy,
   Andre/0000-0002-0613-9164; Kadowaki, Marco Antonio/0000-0003-0188-2079
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP,
   Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2011/20505-4, 2015/13684]; Conselho National de Desenvolvimento
   Cientifico e Tecnolagico (CNPq, Brazil) [405191/2015-4, 303988/20169,
   440977/2016-9, 9423693/2016-6]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP, Brazil) via grants #2011/20505-4 and 2015/13684 and
   Conselho National de Desenvolvimento Cientifico e Tecnolagico (CNPq,
   Brazil) via grants #405191/2015-4, 303988/20169, 440977/2016-9 and
   9423693/2016-6.
CR ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Bhattacharya M, 2016, REV FLUORESC, V8, P1, DOI 10.1007/978-3-319-24609-3_1
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Bornscheuer UT, 2006, HYDROLASES IN ORGANIC SYNTHESIS: REGIO- AND STEREOSELECTIVE BIOTRANSFORMATIONS, 2ND EDITION, P1
   Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4
   BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0
   Camilo CM, 2014, PROTEIN EXPRES PURIF, V99, P35, DOI 10.1016/j.pep.2014.03.008
   Chahinian H, 2009, PROTEIN PEPTIDE LETT, V16, P1149, DOI 10.2174/092986609789071333
   Chakraborty K, 2009, J AGR FOOD CHEM, V57, P3859, DOI 10.1021/jf803797m
   Cousin X, 1996, NUCLEIC ACIDS RES, V24, P132, DOI 10.1093/nar/24.1.132
   Cousin X, 1997, NUCLEIC ACIDS RES, V25, P143, DOI 10.1093/nar/25.1.143
   Davids T, 2013, CURR OPIN CHEM BIOL, V17, P215, DOI 10.1016/j.cbpa.2013.02.022
   Dosanjh NS, 2002, PROTEIN EXPRES PURIF, V24, P71, DOI 10.1006/prep.2001.1528
   Ewis HE, 2004, GENE, V329, P187, DOI 10.1016/j.gene.2003.12.029
   Ferrer M, 2015, BIOCATAL BIOTRANSFOR, V33, P235, DOI 10.3109/10242422.2016.1151416
   Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076
   Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015
   Fojan P, 2000, BIOCHIMIE, V82, P1033, DOI 10.1016/S0300-9084(00)01188-3
   Franke D., 2017, J APPL CRYSTALLOGR, V50
   Garabito MJ, 1998, CAN J MICROBIOL, V44, P95, DOI 10.1139/w97-125
   Hammersley A. P., 1997, ESRF97HA02T
   Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405
   Hotta Y, 2002, APPL ENVIRON MICROB, V68, P3925, DOI 10.1128/AEM.68.8.3925-3931.2002
   Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5
   Javed S, 2018, PROG BIOPHYS MOL BIO, V132, P23, DOI 10.1016/j.pbiomolbio.2017.07.014
   Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0
   Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7
   Kitaura S, 2001, J BIOCHEM-TOKYO, V129, P397, DOI 10.1093/oxfordjournals.jbchem.a002870
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069
   Lotti M., 2007, LIPASES MOL STRUCTUR
   Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188
   Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142
   Mavridis L, 2017, BIOINFORMATICS, V33, P56, DOI 10.1093/bioinformatics/btw554
   Memarpoor-Yazdi M, 2017, FOOD BIOPROD PROCESS, V102, P153, DOI 10.1016/j.fbp.2016.12.015
   Minami H, 2003, ENZYME MICROB TECH, V32, P431, DOI 10.1016/S0141-0229(02)00314-9
   Mondal KC, 2001, J GEN APPL MICROBIOL, V47, P263, DOI 10.2323/jgam.47.263
   Muller-Santos M, 2009, BBA-MOL CELL BIOL L, V1791, P719, DOI 10.1016/j.bbalip.2009.03.006
   Nakamura Aline M., 2017, Biotechnology Research & Innovation, V1, P35, DOI 10.1016/j.biori.2017.02.001
   Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8
   OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197
   Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853
   Rengachari S, 2013, J BIOL CHEM, V288, P31093, DOI 10.1074/jbc.M113.491415
   Rengachari S, 2012, BBA-MOL CELL BIOL L, V1821, P1012, DOI 10.1016/j.bbalip.2012.04.006
   Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Sabri S, 2009, PROTEIN EXPRES PURIF, V68, P161, DOI 10.1016/j.pep.2009.08.002
   Sana B, 2007, PROCESS BIOCHEM, V42, P1571, DOI 10.1016/j.procbio.2007.05.026
   SARDA L, 1958, BIOCHIM BIOPHYS ACTA, V30, P513, DOI 10.1016/0006-3002(58)90097-0
   Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI [10.1139/w03-076, 10.1139/W03-076]
   Schmid RD, 1998, ANGEW CHEM INT EDIT, V37, P1609
   Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461
   SCHONHEYDER F, 1945, ACTA PHYSIOL SCAND, V9, P57, DOI 10.1111/j.1748-1716.1945.tb03084.x
   Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50
   Singh R, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0485-8
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Takenaka S, 2018, BIOTECHNOL LETT, V40, P189, DOI 10.1007/s10529-017-2459-2
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829
   Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0
   Voigt B, 2015, PROTEOMICS, V15, P2629, DOI 10.1002/pmic.201400504
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wang GZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19494
   Wiegand S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-667
   ZAKS A, 1984, SCIENCE, V224, P1249, DOI 10.1126/science.6729453
   Zisis T, 2015, BIOCHEMISTRY-US, V54, P5969, DOI 10.1021/acs.biochem.5b00586
NR 67
TC 3
Z9 4
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD DEC
PY 2018
VL 120
BP 1893
EP 1905
DI 10.1016/j.ijbiomac.2018.10.003
PN B
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA HA0IX
UT WOS:000449892800063
PM 30290254
DA 2020-11-24
ER

PT J
AU Godoy, AS
   Pereira, CS
   Ramia, MP
   Silveira, RL
   Camilo, CM
   Kadowaki, MA
   Lange, L
   Busk, PK
   Nascimento, AS
   Skaf, MS
   Polikarpov, I
AF Godoy, Andre S.
   Pereira, Caroline S.
   Ramia, Marina Paglione
   Silveira, Rodrigo L.
   Camilo, Cesar M.
   Kadowaki, Marco A.
   Lange, Lene
   Busk, Peter K.
   Nascimento, Alessandro S.
   Skaf, Munir S.
   Polikarpov, Igor
TI Structure, computational and biochemical analysis of PcCel45A
   endoglucanase from Phanerochaete chrysosporium and catalytic mechanisms
   of GH45 subfamily C members
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CARBOHYDRATE-ACTIVE ENZYMES; SITE-DIRECTED MUTAGENESIS; PLANT-CELL
   WALLS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; DINITROSALICYLIC ACID;
   ANGSTROM RESOLUTION; BACTERIAL EXPANSIN; FUNGAL CELLULASES; HUMICOLA
   INSOLENS
AB The glycoside hydrolase family 45 (GH45) of carbohydrate modifying enzymes is mostly comprised of beta-1,4-endoglucanases. Significant diversity between the GH45 members has prompted the division of this family into three subfamilies: A, B and C, which may differ in terms of the mechanism, general architecture, substrate binding and cleavage. Here, we use a combination of X-ray crystallography, bioinformatics, enzymatic assays, molecular dynamics simulations and site-directed mutagenesis experiments to characterize the structure, substrate binding and enzymatic specificity of the GH45 subfamily C endoglucanase from Phanerochaete chrysosporium (PcCel45A). We investigated the role played by different residues in the binding of the enzyme to cellulose oligomers of different lengths and examined the structural characteristics and dynamics of PcCel45A that make subfamily C so dissimilar to other members of the GH45 family. Due to the structural similarity shared between PcCel45A and domain I of expansins, comparative analysis of their substrate binding was also carried out. Our bioinformatics sequence analyses revealed that the hydrolysis mechanisms in GH45 subfamily C is not restricted to use of the imidic asparagine as a general base in the "Newton's cradle" catalytic mechanism recently proposed for this subfamily.
C1 [Godoy, Andre S.; Ramia, Marina Paglione; Kadowaki, Marco A.; Nascimento, Alessandro S.; Polikarpov, Igor] Univ Sao Paulo, Sao Carlos Inst Phys, BR-13566590 Sao Paulo, Brazil.
   [Pereira, Caroline S.; Silveira, Rodrigo L.; Skaf, Munir S.] Univ Estadual Campinas, Inst Chem, BR-13084862 Sao Paulo, Brazil.
   [Camilo, Cesar M.] Ctr Tecnol Canavieira, POB 162, BR-13400970 Sao Paulo, Brazil.
   [Lange, Lene; Busk, Peter K.] Tech Univ Denmark, Dept Chem & Biochem Engn, Bldg 229, DK-2800 Lyngby, Denmark.
RP Polikarpov, I (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, BR-13566590 Sao Paulo, Brazil.
EM ipolikarpov@ifsc.usp.br
RI Polikarpov, Igor/D-2575-2012; Godoy, Andre/AAF-2432-2020; Silveira,
   Rodrigo L/I-3961-2014; UNICAMP, CCES -/J-7787-2015; Nascimento,
   Alessandro/Y-3394-2019; Camilo, Cesar M/H-4018-2012; Kamp Busk,
   Peter/Q-8145-2016
OI Godoy, Andre/0000-0002-0613-9164; Silveira, Rodrigo
   L/0000-0001-9515-3082; Nascimento, Alessandro/0000-0001-6656-5379;
   Camilo, Cesar M/0000-0002-3025-5050; Simoes Pereira,
   Caroline/0000-0002-0248-0883; Kadowaki, Marco
   Antonio/0000-0003-0188-2079; Kamp Busk, Peter/0000-0003-1920-636X
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/52362-5,
   11/20505-4, 11/21608-1, 15/13684-0]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [405191/2015-4,
   303988/2016-9, 40977/2016-9]; CAPESCAPES; Universidade de Sao Paulo
   "Centro de Instrumentacao para estudos avancados de materiais
   nanoestruturados e biossistemas"; Universidade de Sao Paulo "Nucleo de
   Apoio a Pesquisa em Bioenergia e Sustentabilidade (NAPBS)"
FX The PcCel45A dataset was collected at the Brookhaven National
   Laboratory, during the RapiData course. This study was supported by the
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) via grants
   10/52362-5, 11/20505-4, 11/21608-1 and 15/13684-0 and the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) via grants
   405191/2015-4, 303988/2016-9 and 440977/2016-9. We also would like to
   acknowledge financial support from CAPES and Universidade de Sao Paulo
   "Centro de Instrumentacao para estudos avancados de materiais
   nanoestruturados e biossistemas" and "Nucleo de Apoio a Pesquisa em
   Bioenergia e Sustentabilidade (NAPBS)". MD simulations were carried out
   at the Center for Computational Engineering & Sciences at the University
   of Campinas.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   BAILEY MJ, 1988, APPL MICROBIOL BIOT, V29, P494, DOI 10.1007/BF00269074
   Busk PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114138
   Busk PK, 2013, APPL ENVIRON MICROB, V79, P3380, DOI 10.1128/AEM.03803-12
   Camilo CM, 2016, J COMPUT BIOL, V23, P27, DOI 10.1089/cmb.2015.0148
   CARDER JH, 1986, ANAL BIOCHEM, V153, P75, DOI 10.1016/0003-2697(86)90063-1
   Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014
   Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000
   Cukier RI, 2004, BBA-BIOENERGETICS, V1655, P37, DOI 10.1016/j.bbabio.2003.06.011
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Davies GJ, 1996, ACTA CRYSTALLOGR D, V52, P7, DOI 10.1107/S0907444995009280
   Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037
   Duan CJ, 2010, APPL ENVIRON MICROB, V76, P4867, DOI 10.1128/AEM.00011-10
   Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037
   Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e
   Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005
   Hirvonen M, 2003, J MOL BIOL, V329, P403, DOI 10.1016/S0022-2836(03)00467-4
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Mohanram S., 2013, SUSTAINABLE CHEM PRO, V1, P1, DOI DOI 10.1186/2043-7129-1-15
   Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263
   Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Prates ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059069
   Rabhi I, 2004, MOL BIOTECHNOL, V26, P27, DOI 10.1385/MB:26:1:27
   Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242
   Schulein M, 1998, BIOCHEM SOC T, V26, P164, DOI 10.1042/bst0260164
   Segato F, 2012, ENZYME MICROB TECH, V51, P100, DOI 10.1016/j.enzmictec.2012.04.008
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104
   TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9
   Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103
NR 48
TC 5
Z9 5
U1 5
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 27
PY 2018
VL 8
AR 3678
DI 10.1038/s41598-018-21798-9
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX5VY
UT WOS:000426151800011
PM 29487297
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Godoy, AS
   Lima, GMA
   Oliveira, KIZ
   Torres, NU
   Maluf, FV
   Guido, RVC
   Oliva, G
AF Godoy, Andre S.
   Lima, Gustavo M. A.
   Oliveira, Ketllyn I. Z.
   Torres, Naiara U.
   Maluf, Fernando V.
   Guido, Rafael V. C.
   Oliva, Glaucius
TI Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase
SO NATURE COMMUNICATIONS
LA English
DT Article
ID STRUCTURE REFINEMENT; DOMAIN; PHENIX
AB The current Zika virus (ZIKV) outbreak became a global health threat of complex epidemiology and devastating neurological impacts, therefore requiring urgent efforts towards the development of novel efficacious and safe antiviral drugs. Due to its central role in RNA viral replication, the non-structural protein 5 (NS5) RNA-dependent RNA-polymerase (RdRp) is a prime target for drug discovery. Here we describe the crystal structure of the recombinant ZIKV NS5 RdRp domain at 1.9 angstrom resolution as a platform for structure-based drug design strategy. The overall structure is similar to other flaviviral homologues. However, the priming loop target site, which is suitable for non-nucleoside polymerase inhibitor design, shows significant differences in comparison with the dengue virus structures, including a tighter pocket and a modified local charge distribution.
C1 [Godoy, Andre S.; Lima, Gustavo M. A.; Oliveira, Ketllyn I. Z.; Torres, Naiara U.; Maluf, Fernando V.; Guido, Rafael V. C.; Oliva, Glaucius] Univ Sao Paulo, Inst Phys Sao Carlos, Ave Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, SP, Brazil.
   [Torres, Naiara U.; Maluf, Fernando V.] Cellco Biotec, R Alberto Lanzoni,993 Parque Santa Felicia, BR-13562390 Sao Carlos, SP, Brazil.
RP Oliva, G (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Ave Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, SP, Brazil.
EM oliva@ifsc.usp.br
RI Godoy, Andre/AAF-2432-2020; Godoy, Andre S/I-1302-2017; Oliva,
   Glaucius/B-9059-2012; Guido, Rafael Victorio Carvalho/A-7450-2009; Lima,
   Gustavo/D-6453-2017
OI Godoy, Andre/0000-0002-0613-9164; Godoy, Andre S/0000-0002-0613-9164;
   Guido, Rafael Victorio Carvalho/0000-0002-7187-0818; Lima,
   Gustavo/0000-0002-0011-5559
FU EMU/FAPESP [2015/16811-3]; Sao Paulo Research Foundation-FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07600-3,
   2014/50381-3, 2016/19712-9, 2016/17153-2]
FX We thank H.M. Pereira for technical assistance with the crystallization
   robot facility (EMU/FAPESP grant 2015/16811-3) and J.R.C. Muniz for data
   collection support at the synchrotron beamline MX2 (LNLS, Campinas).
   Funding from the Sao Paulo Research Foundation-FAPESP (CEPID grant
   2013/07600-3, PIPE grant 2014/50381-3, and fellowships 2016/19712-9,
   2016/17153-2) is gratefully acknowledged.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Anusuya S, 2016, J BIOMOL STRUCT DYN, V34, P1512, DOI 10.1080/07391102.2015.1081620
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Powdrill MH, 2010, VIRUSES-BASEL, V2, P2169, DOI 10.3390/v2102169
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106
   Tarantino D, 2016, ANTIVIR RES, V134, P226, DOI 10.1016/j.antiviral.2016.09.007
   Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X
   Wilkins MR, 1999, METH MOL B, V112, P531
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172
NR 24
TC 54
Z9 57
U1 1
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 27
PY 2017
VL 8
AR 14764
DI 10.1038/ncomms14764
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EP5EL
UT WOS:000397401700003
PM 28345596
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Godoy, AS
   Camilo, CM
   Kadowaki, MA
   Muniz, HD
   Santo, ME
   Murakami, MT
   Nascimento, AS
   Polikarpov, I
AF Godoy, Andre Schutzer
   Camilo, Cesar Moises
   Kadowaki, Marco Antonio
   Muniz, Heloisa dos S.
   Santo, Melissa Espirito
   Murakami, Mario Tyago
   Nascimento, Alessandro S.
   Polikarpov, Igor
TI Crystal structure of beta 1 -> 6-galactosidase from Bifidobacterium
   bifidum S17: trimeric architecture, molecular determinants of the
   enzymatic activity and its inhibition by alpha-galactose
SO FEBS JOURNAL
LA English
DT Article
DE beta-galactosidase; Bifidobacterium bifidum; GH42 family; probiotic;
   X-ray structure
ID THERMOSTABLE BETA-GALACTOSIDASE; ESCHERICHIA-COLI; COLONIC MICROBIOTA;
   GENE CLONING; PURIFICATION; FERMENTATION; OLIGOSACCHARIDES;
   SPECIFICITIES; METABOLISM; CATALYSIS
AB In a search for better comprehension of beta-galactosidase function and specificity, we solved the crystal structures of the GH42 beta-galactosidase BbgII from Bifidobacterium bifidum S17, a well-adapted probiotic microorganism from the human digestive tract, and its complex with D-alpha-galactose. BbgII is a three-domain molecule that forms barrel-shaped trimers in solution. BbgII interactions with D-alpha-galactose, a competitive inhibitor, showed a number of residues that are involved in the coordination of ligands. A combination of site-directed mutagenesis of these amino acid residues with enzymatic activity measurements confirmed that Glu161 and Glu320 are fundamental for catalysis and their substitution by alanines led to catalytically inactive mutants. Mutation Asn160Ala resulted in a two orders of magnitude decrease of the enzyme k(cat) without significant modification in its K-m, whereas mutations Tyr289Phe and His371Phe simultaneously decreased k(cat) and increased K-m values. Enzymatic activity of Glu368Ala mutant was too low to be detected. Our docking and molecular dynamics simulations showed that the enzyme recognizes and tightly binds substrates with beta 1 -> 6 and beta 1 -> 3 bonds, while binding of the substrates with beta 1 -> 4 linkages is less favorable.
   Database
   Structural data are available in the PDB under the accession numbers 4UZS and 4UCF
C1 [Godoy, Andre Schutzer; Kadowaki, Marco Antonio; Muniz, Heloisa dos S.; Santo, Melissa Espirito; Nascimento, Alessandro S.; Polikarpov, Igor] Univ Sao Paulo, Dept Fis Sao Carlos, 400 Ave Trabalhador Saocarlense, BR-13560970 Sao Carlos, SP, Brazil.
   [Camilo, Cesar Moises] Ctr Tecnol Canavieira, Piracicaba, Brazil.
   [Murakami, Mario Tyago] Natl Ctr Energy & Mat Res, Biosci Natl Lab, Campinas, SP, Brazil.
RP Polikarpov, I (corresponding author), Univ Sao Paulo, Dept Fis Sao Carlos, 400 Ave Trabalhador Saocarlense, BR-13560970 Sao Carlos, SP, Brazil.
EM ipolikarpov@ifsc.usp.br
RI Camilo, Cesar M/H-4018-2012; Godoy, Andre/AAF-2432-2020; Godoy, Andre
   S/I-1302-2017; Santo, Melissa Espirito/AAG-6103-2020; Murakami, Mario
   T/F-5640-2016; Santo, Melissa Espirito/ABB-5947-2020; Nascimento,
   Alessandro/Y-3394-2019; Nascimento, Alessandro S/G-9547-2012;
   Polikarpov, Igor/D-2575-2012
OI Camilo, Cesar M/0000-0002-3025-5050; Godoy, Andre/0000-0002-0613-9164;
   Godoy, Andre S/0000-0002-0613-9164; Santo, Melissa
   Espirito/0000-0002-2803-4240; Murakami, Mario T/0000-0002-0405-8010;
   Nascimento, Alessandro/0000-0001-6656-5379; Nascimento, Alessandro
   S/0000-0001-6656-5379; Polikarpov, Igor/0000-0001-9496-4174
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56255-9,
   2009/52840-7, 2009/05328-9, 2011/05712-3, 2011/20505-4, 2014/06565-2];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [490022/2009-0, 301981/2011-6, 400045/2012-5, 485950/2013-8];
   CAPESCAPES; Universidade de Sao Paulo 'Centro de Instrumentacao para
   estudos avancados de materiais nanoestruturados e biossistemas';
   Universidade de Sao Paulo 'Nucleo de Apoio a Pesquisa em Bioenergia e
   Sustentabilidade (NAPBS)'
FX We thank Professor Christian Riedel from Ulm University, Germany, for
   donating us the strain of B. bifidum S17; Amanda Bernardes and Mario
   Oliveira Neto for their help with thermofour and SAXS measurements,
   respectively. We also acknowledge the grants from Brazilian funding
   agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   #2008/56255-9, 2009/52840-7, 2009/05328-9, 2011/05712-3, 2011/20505-4
   and 2014/06565-2; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) #490022/2009-0, 301981/2011-6, 400045/2012-5 and
   485950/2013-8; CAPES and Universidade de Sao Paulo 'Centro de
   Instrumentacao para estudos avancados de materiais nanoestruturados e
   biossistemas' and 'Nucleo de Apoio a Pesquisa em Bioenergia e
   Sustentabilidade (NAPBS)'.
CR Aboulfazli F, 2015, INT J FOOD SCI TECH, V50, P942, DOI 10.1111/ijfs.12723
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Andreani R, 2008, SIAM J OPTIMIZ, V18, P1286, DOI 10.1137/060654797
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Camilo CM, 2016, J COMPUT BIOL, V23, P27, DOI 10.1089/cmb.2015.0148
   Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Chen W, 2008, J DAIRY SCI, V91, P1751, DOI 10.3168/jds.2007-617
   Coombs JM, 1999, APPL ENVIRON MICROB, V65, P5443
   Dong YN, 2015, J DAIRY SCI, V98, P2268, DOI 10.3168/jds.2014-9117
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479
   Gomi A, 2015, J DAIRY SCI, V98, P2277, DOI 10.3168/jds.2014-9158
   Goulas T, 2009, APPL MICROBIOL BIOT, V82, P1079, DOI 10.1007/s00253-008-1795-5
   Goulas TK, 2007, APPL MICROBIOL BIOT, V76, P1365, DOI 10.1007/s00253-007-1099-1
   Hammersley A. P., 1997, ESRF97HA02T
   Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5
   Hildebrandt P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-151
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795
   Husain Q, 2010, CRIT REV BIOTECHNOL, V30, P41, DOI 10.3109/07388550903330497
   Iqbal S, 2010, CARBOHYD RES, V345, P1408, DOI 10.1016/j.carres.2010.03.028
   JONES DR, 1993, J OPTIMIZ THEORY APP, V79, P157, DOI 10.1007/BF00941892
   Juajun O, 2011, APPL MICROBIOL
   Juers DH, 2003, BIOCHEMISTRY-US, V42, P13505, DOI 10.1021/bi035506j
   Juers DH, 2001, BIOCHEMISTRY-US, V40, P14781, DOI 10.1021/bi011727i
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kaplan H, 2000, APPL ENVIRON MICROB, V66, P2682, DOI 10.1128/AEM.66.6.2682-2684.2000
   Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02
   Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820
   Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341
   Klijn A, 2005, FEMS MICROBIOL REV, V29, P491, DOI 10.1016/j.femsre.2005.04.010
   Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x
   Maksimainen M, 2012, FEBS J, V279, P1788, DOI 10.1111/j.1742-4658.2012.08555.x
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Muniz HD, 2015, J COMPUT AID MOL DES, V29, P713, DOI 10.1007/s10822-015-9856-1
   O'Keefe SJD, 2009, J NUTR, V139, P2044, DOI 10.3945/jn.109.104380
   Ohtsu N, 1998, BIOSCI BIOTECH BIOCH, V62, P1539, DOI 10.1271/bbb.62.1539
   Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d
   Pan Q, 2010, CURR MICROBIOL, V60, P172, DOI 10.1007/s00284-009-9521-9
   Park AR, 2010, APPL MICROBIOL BIOT, V85, P1279, DOI 10.1007/s00253-009-2356-2
   Peacock KS, 2013, J AGR FOOD CHEM, V61, P12612, DOI 10.1021/jf403789r
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Rabhi I, 2004, MOL BIOTECHNOL, V26, P27, DOI 10.1385/MB:26:1:27
   Richard JP, 1996, BIOCHEMISTRY-US, V35, P12377, DOI 10.1021/bi961028j
   SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X
   Shaikh FA, 2007, FEBS LETT, V581, P2441, DOI 10.1016/j.febslet.2007.04.053
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Sheridan PP, 2000, APPL ENVIRON MICROB, V66, P2438, DOI 10.1128/AEM.66.6.2438-2444.2000
   Slovakova L, 2002, LETT APPL MICROBIOL, V35, P126, DOI 10.1046/j.1472-765X.2002.01159.x
   Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107
   Viborg AH, 2014, GLYCOBIOLOGY, V24, P208, DOI 10.1093/glycob/cwt104
   Viborg AH, 2014, MOL MICROBIOL, V94, P1024, DOI 10.1111/mmi.12815
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215
   Yuan TZ, 2008, BIOTECHNOL LETT, V30, P343, DOI 10.1007/s10529-007-9551-y
   Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172
NR 68
TC 9
Z9 9
U1 0
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD NOV
PY 2016
VL 283
IS 22
BP 4097
EP 4112
DI 10.1111/febs.13908
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EC6ZX
UT WOS:000388286300006
PM 27685756
DA 2020-11-24
ER

PT J
AU Godoy, AS
   de Lima, MZT
   Camilo, CM
   Polikarpov, I
AF Godoy, Andre S.
   de Lima, Mariana Z. T.
   Camilo, Cesar M.
   Polikarpov, Igor
TI Crystal structure of a putative exo-beta-1,3-galactanase from
   Bifidobacterium bifidum S17
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
DE galactanase; Bifidobacterium; GH43; family 43; hydrolase
ID FEATURES
AB Given the current interest in second-generation biofuels, carbohydrate-active enzymes have become the most important tool to overcome the structural recalcitrance of the plant cell wall. While some glycoside hydrolase families have been exhaustively described, others remain poorly characterized, especially with regard to structural information. The family 43 glycoside hydrolases are a diverse group of inverting enzymes; the available structure information on these enzymes is mainly from xylosidases and arabinofuranosidase. Currently, only one structure of an exo-beta-1,3-galactanase is available. Here, the production, crystallization and structure determination of a putative exo-beta-1,3-galactanase from Bifidobacterium bifidum S17 (BbGal43A) are described. BbGal43A was successfully produced and showed activity towards synthetic galactosides. BbGal43A was subsequently crystallized and data were collected to 1.4 angstrom resolution. The structure shows a single-domain molecule, differing from known homologues, and crystal contact analysis predicts the formation of a dimer in solution. Further biochemical studies are necessary to elucidate the differences between BbGal43A and its characterized homologues.
C1 [Godoy, Andre S.; de Lima, Mariana Z. T.; Polikarpov, Igor] Univ Sao Paulo, Dept Fis Sao Carlos, Ave Trabalhador Saocarlense 400, BR-13560970 Sao Carlos, SP, Brazil.
   [Camilo, Cesar M.] Ctr Tecnol Canavieira, Fazenda Santo Antonio, POB 162, BR-13400970 Piracicaba, SP, Brazil.
RP Polikarpov, I (corresponding author), Univ Sao Paulo, Dept Fis Sao Carlos, Ave Trabalhador Saocarlense 400, BR-13560970 Sao Carlos, SP, Brazil.
EM ipolikarpov@if.sc.usp.br
RI Godoy, Andre/AAF-2432-2020; de Lima, Mariana Zuliani
   Theodoro/AAT-8220-2020; Godoy, Andre S/I-1302-2017; Polikarpov,
   Igor/D-2575-2012; Camilo, Cesar M/H-4018-2012
OI Godoy, Andre/0000-0002-0613-9164; de Lima, Mariana Zuliani
   Theodoro/0000-0002-6592-5149; Godoy, Andre S/0000-0002-0613-9164;
   Camilo, Cesar M/0000-0002-3025-5050; Polikarpov,
   Igor/0000-0001-9496-4174
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56255-9,
   2009/52840-7, 2009/05328-9, 2011/05712-3, 2011/20505-4]
FX We would like to thank Professor Professor Christian Riedel from Ulm
   University, Germany for donating B. bifidum S17, as well as the RapiData
   2013 organization committee. We would also like to acknowledge the
   grants from the Brazilian funding agencies Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP; Nos. 2008/56255-9, 2009/52840-7,
   2009/05328-9, 2011/05712-3 and 2011/20505-4) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq; Nos. 490022/2009-0,
   301981/2011-6 and 400045/2012-5), CAPES and Universidade de Sao Paulo
   'Centro de Instrumentacao para Estudos Avancados de Materiais
   Nanoestruturados e Biossistemas' and 'Nucleo de Apoio a Pesquisa em
   Bioenergia e Sustentabilidade (NAPBS)'
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200
   Jiang DH, 2012, J STRUCT BIOL, V180, P447, DOI 10.1016/j.jsb.2012.08.005
   Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mohanram S., 2013, SUSTAINABLE CHEM PRO, V1, P1, DOI DOI 10.1186/2043-7129-1-15
   Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Wilkins MR, 1999, METH MOL B, V112, P531
NR 18
TC 1
Z9 1
U1 0
U2 10
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD APR
PY 2016
VL 72
BP 288
EP 293
DI 10.1107/S2053230X16003617
PN 4
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA DI7ZK
UT WOS:000373720300006
PM 27050262
OA Green Published
DA 2020-11-24
ER

PT J
AU Pellegrini, VOA
   Serpa, VI
   Godoy, AS
   Camilo, CM
   Bernardes, A
   Rezende, CA
   Pereira, N
   Cairo, JPLF
   Squina, FM
   Polikarpov, I
AF Pellegrini, Vanessa O. A.
   Serpa, Viviane Isabel
   Godoy, Andre S.
   Camilo, Cesar M.
   Bernardes, Amanda
   Rezende, Camila A.
   Pereira Junior, Nei
   Cairo, Joao Paulo L. Franco
   Squina, Fabio M.
   Polikarpov, Igor
TI Recombinant Trichoderma harzianum endoglucanase I (Cel7B) is a highly
   acidic and promiscuous carbohydrate-active enzyme
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Trichoderma harzianum; Second-generation ethanol; Cellulase;
   Endoglucanase; Aspergillus niger
ID CELLULOSE DEGRADATION; ASPERGILLUS-NIDULANS; ETHANOL-PRODUCTION; REESEI;
   HYDROLYSIS; CELLULASES; CELLOBIOHYDROLASE; CLONING; IDENTIFICATION;
   TRANSFORMATION
AB Trichoderma filamentous fungi have been investigated due to their ability to secrete cellulases which find various biotechnological applications such as biomass hydrolysis and cellulosic ethanol production. Previous studies demonstrated that Trichoderma harzianum IOC-3844 has a high degree of cellulolytic activity and potential for biomass hydrolysis. However, enzymatic, biochemical, and structural studies of cellulases from T. harzianum are scarce. This work reports biochemical characterization of the recombinant endoglucanase I from T. harzianum, ThCel7B, and its catalytic core domain. The constructs display optimum activity at 55 A degrees C and a surprisingly acidic pH optimum of 3.0. The full-length enzyme is able to hydrolyze a variety of substrates, with high specific activity: 75 U/mg for beta-glucan, 46 U/mg toward xyloglucan, 39 U/mg for lichenan, 26 U/mg for carboxymethyl cellulose, 18 U/mg for 4-nitrophenyl beta-d-cellobioside, 16 U/mg for rye arabinoxylan, and 12 U/mg toward xylan. The enzyme also hydrolyzed filter paper, phosphoric acid swollen cellulose, Sigmacell 20, Avicel PH-101, and cellulose, albeit with lower efficiency. The ThCel7B catalytic domain displays similar substrate diversity. Fluorescence-based thermal shift assays showed that thermal stability is highest at pH 5.0. We determined kinetic parameters and analyzed a pattern of oligosaccharide substrates hydrolysis, revealing cellobiose as a final product of C6 degradation. Finally, we visualized effects of ThCel7B on oat spelt using scanning electron microscopy, demonstrating the morphological changes of the substrate during the hydrolysis. The acidic behavior of ThCel7B and its considerable thermostability hold a promise of its industrial applications and other biotechnological uses under extremely acidic conditions.
C1 [Pellegrini, Vanessa O. A.; Serpa, Viviane Isabel; Godoy, Andre S.; Camilo, Cesar M.; Bernardes, Amanda; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis Informat, BR-13566590 Sao Carlos, SP, Brazil.
   [Rezende, Camila A.] Univ Estadual Campinas, Inst Quim, BR-13083970 Campinas, SP, Brazil.
   [Pereira Junior, Nei] Univ Fed Rio de Janeiro, Dept Engn Bioquim, Escola Quim, BR-21949900 Rio De Janeiro, RJ, Brazil.
   [Cairo, Joao Paulo L. Franco; Squina, Fabio M.] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTB, BR-13083970 Campinas, SP, Brazil.
RP Polikarpov, I (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis Informat, Av Trabalhador Saocarlense 400, BR-13566590 Sao Carlos, SP, Brazil.
EM ipolikarpov@ifsc.usp.br
RI Rezende, Camila A/C-3914-2012; Junior, Nei Pereira/H-2471-2016;
   Polikarpov, Igor/D-2575-2012; Camilo, Cesar M/H-4018-2012; Arnoldi,
   Vanessa/I-6667-2015; Squina, Fabio M/J-8130-2012; Godoy,
   Andre/AAF-2432-2020; Cairo, Joao Paulo L Franco/A-3423-2013; Godoy,
   Andre S/I-1302-2017
OI Rezende, Camila A/0000-0002-2072-1361; Camilo, Cesar
   M/0000-0002-3025-5050; Godoy, Andre/0000-0002-0613-9164; Cairo, Joao
   Paulo L Franco/0000-0002-4744-3111; Godoy, Andre S/0000-0002-0613-9164;
   Polikarpov, Igor/0000-0001-9496-4174
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56255-9,
   2009/52840-7, 2009/05328-9, 2010/18773-8, 2011/20977-3, 2011/05712-3];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [490022/2009-0, 301981/2011-6, 400045/2012-5]; CAPESCAPES;
   Universidade de Sao Paulo via grant "Centro de Instrumentacao para
   estudos avancados de materiais nanoestruturados e biossistemas";
   Universidade de Sao Paulo via grant "Nucleo de Apoio a Pesquisa em
   Bioenergia e Sustentabilidade (NAPBS)"
FX We would like to acknowledge support of the Brazilian funding agencies
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) via grants
   #2008/56255-9, 2009/52840-7, 2009/05328-9, 2010/18773-8, 2011/20977-3,
   and 2011/05712-3; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) via grants #490022/2009-0, 301981/2011-6 and,
   400045/2012-5; CAPES and Universidade de Sao Paulo via grants "Centro de
   Instrumentacao para estudos avancados de materiais nanoestruturados e
   biossistemas" and "Nucleo de Apoio a Pesquisa em Bioenergia e
   Sustentabilidade (NAPBS)."
CR Badhan A, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-31
   BAILEY MJ, 1993, BIOTECHNOL APPL BIOC, V17, P65
   Becker D, 2001, BIOCHEM J, V356, P19, DOI 10.1042/0264-6021:3560019
   Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0
   BIELY P, 1991, EUR J BIOCHEM, V200, P157, DOI 10.1111/j.1432-1033.1991.tb21062.x
   Bubner P, 2013, BIOTECHNOL BIOENG, V110, P1529, DOI 10.1002/bit.24884
   BUCKERIDGE MS, 2010, SUGARCANE BIOETHANOL, P365
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205
   Colussi F, 2012, EUR BIOPHYS J BIOPHY, V41, P89, DOI 10.1007/s00249-011-0762-8
   de Castro AM, 2010, J IND MICROBIOL BIOT, V37, P151, DOI 10.1007/s10295-009-0656-2
   Dias MOS, 2012, BIORESOURCE TECHNOL, V103, P152, DOI 10.1016/j.biortech.2011.09.120
   Ding SJ, 2001, EUR J BIOCHEM, V268, P5687, DOI 10.1046/j.0014-2956.2001.02503.x
   Eriksson T, 2004, EUR J BIOCHEM, V271, P1266, DOI 10.1111/j.1432-1033.2004.04031.x
   Ganner T, 2012, J BIOL CHEM, V287, P43215, DOI 10.1074/jbc.M112.419952
   Garcia R, 2001, BIOTECHNOL APPL BIOC, V33, P141, DOI 10.1042/BA20000085
   Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000
   Hasper AA, 2002, APPL ENVIRON MICROB, V68, P1556, DOI 10.1128/AEM.68.4.1556-1560.2002
   Hilden L, 2005, J BIOTECHNOL, V118, P386, DOI 10.1016/j.jbiotec.2005.05.001
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45
   KALSNER I, 1995, GLYCOCONJUGATE J, V12, P360, DOI 10.1007/BF00731339
   Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6
   Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571
   Kim HM, 2012, J IND MICROBIOL BIOT, V39, P1081, DOI 10.1007/s10295-012-1110-4
   Kont R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-135
   Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   Mikkelson A, 2013, CARBOHYD RES, V372, P60, DOI 10.1016/j.carres.2013.02.012
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Miotto LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108393
   Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891
   Naran R, 2007, PLANT J, V50, P95, DOI 10.1111/j.1365-313X.2007.03033.x
   Okada H, 1998, APPL ENVIRON MICROB, V64, P555
   Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110
   PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7
   Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9
   Saha BC, 2004, PROCESS BIOCHEM, V39, P1871, DOI 10.1016/j.procbio.2003.09.013
   Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013
   Sandgren M, 2005, PROG BIOPHYS MOL BIO, V89, P246, DOI 10.1016/j.pbiomolbio.2004.11.002
   Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1
   Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710
   Serpa VI, 2011, ROUTES TO CELLULOSIC ETHANOL, P97, DOI 10.1007/978-0-387-92740-4_7
   Storms R, 2005, PLASMID, V53, P191, DOI 10.1016/j.plasmid.2004.10.001
   Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7
   Suurnakki A, 2000, CELLULOSE, V7, P189, DOI 10.1023/A:1009280109519
   Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9
   Varnai A, 2011, BIORESOURCE TECHNOL, V102, P9096, DOI 10.1016/j.biortech.2011.06.059
   Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057
   Voutilainen SP, 2009, APPL MICROBIOL BIOT, V83, P261, DOI 10.1007/s00253-008-1848-9
   Wang JP, 2012, LANGMUIR, V28, P9664, DOI 10.1021/la301030f
   WOOD TM, 1988, METHOD ENZYMOL, V160, P19
   Xiang L, 2014, PROTEIN EXPRES PURIF, V102, P20, DOI 10.1016/j.pep.2014.07.009
   YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470
   Zhao SM, 2010, J MICROBIOL BIOTECHN, V20, P467, DOI 10.4014/jmb.0908.08028
NR 55
TC 13
Z9 13
U1 1
U2 30
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD NOV
PY 2015
VL 99
IS 22
BP 9591
EP 9604
DI 10.1007/s00253-015-6772-1
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CV0PB
UT WOS:000363951800023
PM 26156238
DA 2020-11-24
ER

PT J
AU Bernardes, A
   Souza, PCT
   Muniz, JRC
   Ricci, CG
   Ayers, SD
   Parekh, NM
   Godoy, AS
   Trivella, DBB
   Reinach, P
   Webb, P
   Skaf, MS
   Polikarpov, I
AF Bernardes, Amanda
   Souza, Paulo C. T.
   Muniz, Joao R. C.
   Ricci, Clarisse G.
   Ayers, Stephen D.
   Parekh, Nili M.
   Godoy, Andre S.
   Trivella, Daniela B. B.
   Reinach, Peter
   Webb, Paul
   Skaf, Munir S.
   Polikarpov, Igor
TI Molecular Mechanism of Peroxisome Proliferator-Activated Receptor alpha
   Activation by WY14643: a New Mode of Ligand Recognition and Receptor
   Stabilization
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE PPAR alpha; crystal structure; protein and ligand interaction; dry eye
   disease; molecular dynamics
ID THYROID-HORMONE RECEPTORS; PPAR-GAMMA LIGAND; RETINOIC ACID RECEPTOR;
   BINDING DOMAIN; DYNAMICS SIMULATIONS; STRUCTURAL BASIS; SELECTIVITY;
   AGONISTS; POTENT; DISCOVERY
AB Peroxisome proliferator-activated receptors (PPARs) are members of a superfamily of nuclear transcription factors. They are involved in mediating numerous physiological effects in humans, including glucose and lipid metabolism. PPAR alpha ligands effectively treat dyslipidemia and have significant antiinflammatory and anti-atherosclerotic activities. These effects and their ligand-dependent activity make nuclear receptors obvious targets for drug design. Here, we present the structure of the human PPAR alpha in complex with WY14643, a member of fibrate class of drug, and a widely used PPAR activator. The crystal structure of this complex suggests that WY14643 induces activation of PPAR alpha in an unusual bipartite mechanism involving conventional direct helix 12 stabilization and an alternative mode that involves a second ligand in the pocket. We present structural observations, molecular dynamics and activity assays that support the importance of the second site in WY14643 action. The unique binding mode of WY14643 reveals a new pattern of nuclear receptor ligand recognition and suggests a novel basis for ligand design, offering clues for improving the binding affinity and selectivity of ligand. We show that binding of WY14643 to PPAR alpha was associated with antiinflammatory disease in a human corneal cell model, suggesting possible applications for PPAR alpha ligands. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Bernardes, Amanda; Muniz, Joao R. C.; Godoy, Andre S.; Polikarpov, Igor] Univ Sao Paulo, Inst Phys Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
   [Souza, Paulo C. T.; Ricci, Clarisse G.; Skaf, Munir S.] Univ Estadual Campinas, Inst Chem, BR-13084862 Campinas, SP, Brazil.
   [Ayers, Stephen D.; Webb, Paul] Methodist Hosp, Res Inst, Ctr Diabet, Houston, TX 77030 USA.
   [Ayers, Stephen D.; Webb, Paul] Methodist Hosp, Res Inst, Canc Res Unit, Houston, TX 77030 USA.
   [Parekh, Nili M.; Reinach, Peter] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA.
   [Trivella, Daniela B. B.] Natl Ctr Res Energy & Mat, Natl Biosci Lab, BR-13083100 Campinas, SP, Brazil.
RP Polikarpov, I (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Ave Trabalhador Saocarlense 400, BR-13560970 Sao Carlos, SP, Brazil.
EM ipolikarpov@ifsc.usp.br
RI Ayers, Stephen D/O-4535-2014; Muniz, Joao R/B-7782-2016; Bernardes,
   Amanda/H-8910-2012; Skaf, Munir S/B-1614-2013; Souza, Paulo
   CT/E-5072-2013; UNICAMP, CCES -/J-7787-2015; Trivella, Daniela B
   B/L-5685-2013; Godoy, Andre S/I-1302-2017; Polikarpov, Igor/D-2575-2012;
   de Souza, Paulo Cesar Telles/ABD-8353-2020; trivella, daniela b
   b/K-2328-2012; Godoy, Andre/AAF-2432-2020
OI Ayers, Stephen D/0000-0003-1390-8969; Muniz, Joao R/0000-0003-2731-3966;
   Skaf, Munir S/0000-0001-7485-1228; Souza, Paulo CT/0000-0003-0660-1301;
   Trivella, Daniela B B/0000-0002-7505-2345; Godoy, Andre
   S/0000-0002-0613-9164; de Souza, Paulo Cesar Telles/0000-0003-0660-1301;
   Godoy, Andre/0000-0002-0613-9164; Polikarpov, Igor/0000-0001-9496-4174
FU FAPESP (Sao Paulo Research Foundation)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [DK41482]
FX We thank Laboratorio Nacional de Luz Sincroton (Brazil) for access to
   the W01B-MX2 beamline and others facilities. This work was supported by
   FAPESP (Sao Paulo Research Foundation) and National Institutes of Health
   Grant DK41482 to P.W.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408
   Amato AA, 2012, J BIOL CHEM, V287, P28169, DOI 10.1074/jbc.M111.332106
   Ambrosio ALB, 2007, J BIOL CHEM, V282, P18625, DOI 10.1074/jbc.M702538200
   ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Batista FAH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033643
   Benardeau A, 2009, BIOORG MED CHEM LETT, V19, P2468, DOI 10.1016/j.bmcl.2009.03.036
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   Berrabah W, 2011, FEBS LETT, V585, P1640, DOI 10.1016/j.febslet.2011.03.066
   Bleicher L, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-8
   Blondel A, 1999, J MOL BIOL, V291, P101, DOI 10.1006/jmbi.1999.2879
   Bonazzi A, 2000, J BIOL CHEM, V275, P2837, DOI 10.1074/jbc.275.4.2837
   Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0
   Brelivet Y, 2012, MOL CELL ENDOCRINOL, V348, P466, DOI 10.1016/j.mce.2011.08.015
   Briguglio E, 2010, PPAR RES, V2010, DOI 10.1155/2010/193019
   Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014
   Bulynko YA, 2011, BIOCHEMISTRY-US, V50, P313, DOI 10.1021/bi101762x
   Carlsson P, 2006, BIOPHYS J, V91, P3151, DOI 10.1529/biophysj.106.082917
   Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0
   Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Filip-Ciubotaru Florina, 2011, Rev Med Chir Soc Med Nat Iasi, V115, P477
   Genest D, 2008, EUR BIOPHYS J BIOPHY, V37, P369, DOI 10.1007/s00249-007-0220-9
   Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464
   Grether U, 2009, CHEMMEDCHEM, V4, P951, DOI 10.1002/cmdc.200800425
   Grundy SM, 2005, AM J CARDIOL, V95, P462, DOI 10.1016/j.amjcard.2004.10.012
   Han HO, 2007, BIOORG MED CHEM LETT, V17, P937, DOI 10.1016/j.bmcl.2006.11.050
   Hansson A, 2011, INT J QUANTUM CHEM, V111, P1346, DOI 10.1002/qua.22638
   HSU MH, 1995, MOL PHARMACOL, V48, P559
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jin LH, 2011, J BIOL CHEM, V286, P31473, DOI 10.1074/jbc.M111.266023
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kersten S, 2000, NATURE, V405, P421
   Kleemann R, 2004, BLOOD, V103, P4188, DOI 10.1182/blood-2003-11-3791
   Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012
   Lannutti F, 2011, J MOL GRAPH MODEL, V29, P865, DOI 10.1016/j.jmgm.2011.02.002
   Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406
   Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107
   Li J, 2010, J MED CHEM, V53, P2854, DOI 10.1021/jm9016812
   Liberato MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036297
   Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Martinez L, 2006, J MED CHEM, V49, P23, DOI 10.1021/jm050805n
   Martinez L, 2005, BIOPHYS J, V89, P2011, DOI 10.1529/biophysj.105.063818
   Martinez L, 2008, J PHYS CHEM B, V112, P10741, DOI 10.1021/jp803403c
   Martinez L, 2009, P NATL ACAD SCI USA, V106, P20717, DOI 10.1073/pnas.0911024106
   Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5
   Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006
   Na KS, 2012, INVEST OPHTH VIS SCI, V53, P5443, DOI 10.1167/iovs.11-9417
   Nolte RT, 1998, NATURE, V395, P137
   Oyama T, 2009, ACTA CRYSTALLOGR D, V65, P786, DOI 10.1107/S0907444909015935
   Pan Z, 2011, INVEST OPHTH VIS SCI, V52, P485, DOI 10.1167/iovs.10-5801
   Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Prates ET, 2011, INT J QUANTUM CHEM, V111, P1339, DOI 10.1002/qua.22701
   Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216
   Rau O, 2008, ARCH PHARM, V341, P191, DOI 10.1002/ardp.200700209
   REDDY JK, 1982, ANN NY ACAD SCI, V386, P81, DOI 10.1111/j.1749-6632.1982.tb21409.x
   Saika S, 2007, CORNEA, V26, pS70, DOI 10.1097/ICO.0b013e31812f6d14
   Samarasinghe SP, 2009, OBESITY, V17, P965, DOI 10.1038/oby.2008.629
   SANTILLI AA, 1974, EXPERIENTIA, V30, P1110, DOI 10.1007/BF01923636
   Shipley JM, 2004, TOXICOL SCI, V80, P151, DOI 10.1093/toxsci/kfh130
   Sierra ML, 2007, J MED CHEM, V50, P685, DOI 10.1021/jm058056x
   Silveira RL, 2012, J PHYS CHEM B, V116, P5671, DOI 10.1021/jp3017858
   Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278
   van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d
   Verlet L., 1967, PHYS REV, V21, P1531
   Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039
   Waku T, 2009, FEBS LETT, V583, P320, DOI 10.1016/j.febslet.2008.12.017
   Wang W, 2008, BIOORG MED CHEM LETT, V18, P1939, DOI 10.1016/j.bmcl.2008.01.126
   Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198
   Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325
   Zhang JZ, 2010, INT J TOXICOL, V29, P496, DOI 10.1177/1091581810376674
NR 79
TC 62
Z9 62
U1 3
U2 46
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 23
PY 2013
VL 425
IS 16
BP 2878
EP 2893
DI 10.1016/j.jmb.2013.05.010
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 200TO
UT WOS:000323094000005
PM 23707408
OA Green Published
DA 2020-11-24
ER

PT J
AU Bernardes, A
   Godoy, AS
   Trivella, DBB
   Muniz, JRC
   Polikarpov, I
AF Bernardes, Amanda
   Godoy, Andre S.
   Trivella, Daniela B. B.
   Muniz, Joao Renato C.
   Polikarpov, Igor
TI Crystal Structures of PPAR alpha in Complex with Synthetic and Natural
   Ligands
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE nuclear_receptor; crystallography; ligand
C1 [Bernardes, Amanda; Godoy, Andre S.; Trivella, Daniela B. B.; Polikarpov, Igor] Univ Sao Paulo, Dept Phys, Sao Carlos, SP, Brazil.
   [Muniz, Joao Renato C.] Univ Oxford, Struct Genom Consortium, Oxford, England.
EM abernardes@ursa.ifsc.usp.br
CR Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0
   Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006
NR 2
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2011
VL 67
SU S
MA MS16.P26
BP C295
EP C296
DI 10.1107/S0108767311092609
PG 2
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI4FT
UT WOS:000484219401234
DA 2020-11-24
ER

PT J
AU Nualart, FJ
   Rivas, CI
   Montecinos, VP
   Godoy, AS
   Guaiquil, VH
   Golde, DW
   Vera, JC
AF Nualart, FJ
   Rivas, CI
   Montecinos, VP
   Godoy, AS
   Guaiquil, VH
   Golde, DW
   Vera, JC
TI Recycling of vitamin C by a bystander effect
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RECOMMENDED DIETARY ALLOWANCE; ASCORBIC-ACID TRANSPORT; DEHYDROASCORBIC
   ACID; NADPH OXIDASE; FACILITATED TRANSPORT; HL-60 CELLS; ACCUMULATION;
   EXPRESSION; GLUCOSE; ANTIOXIDANT
AB Human cells transport dehydroascorbic acid through facilitative glucose transporters, in apparent contradiction with evidence indicating that vitamin C is present in human blood only as ascorbic acid. On the other hand, activated host defense cells undergoing the oxidative burst show increased vitamin C accumulation. We analyzed the role of the oxidative burst and the glucose transporters on vitamin C recycling in an in vitro system consisting of activated host-defense cells co-cultured with human cell lines and primary cells. We asked whether human cells can acquire vitamin C by a "bystander effect" by taking up dehydroascorbic acid generated from extracellular ascorbic acid by neighboring cells undergoing the oxidative burst. As activated cells, we used HL-60 neutrophils and normal human neutrophils activated with phorbol 12 myristate 13-acetate. As bystander cells, we used immortalized cell lines and primary cultures of human epithelial and endothelial cells. Activated cells produced superoxide anions that oxidized. extracellular ascorbic acid to dehydroascorbic acid. At the same time, there was a marked increase in vitamin C uptake by the bystander cells that was blocked by superoxide dismutase but not by catalase and was inhibited by the glucose transporter inhibitor cytochalasin B. Only ascorbic acid was accumulated intracellularly by the bystander cells. Glucose partially blocked vitamin C uptake by the bystander cells, although it increased superoxide production by the activated cells. We conclude that the local production of superoxide anions by activated cells causes the oxidation of extracellular ascorbic acid to dehydroascorbic acid, which is then transported by neighboring cells through the glucose transporters and immediately reduced to ascorbic acid intracellularly. In addition to causing increased intracellular concentrations of ascorbic acid with likely associated enhanced antioxidant defense mechanisms, the bystander effect may allow the recycling of vitamin C in vivo, which may contribute to the low daily requirements of the vitamin in humans.
C1 Univ Concepcion, Fac Ciencias Biol, Dept Fisiopatol, Concepcion, Chile.
   Univ Concepcion, Fac Ciencias Biol, Dept Histol & Embriol, Concepcion, Chile.
   Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA.
RP Vera, JC (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Fisiopatol, Barrio Univ S-N, Concepcion, Chile.
EM juvera@udec.cl
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [CA30388] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) [R37CA030388,
   R01CA030388, R01CA030388, R01CA030388, R01CA030388, R01CA030388,
   R37CA030388, R01CA030388, R01CA030388, R37CA030388, R01CA030388,
   R37CA030388, R01CA030388, R37CA030388, R01CA030388, R01CA030388,
   R37CA030388, R37CA030388, R37CA030388, R37CA030388] Funding Source: NIH
   RePORTER
CR Agus DB, 1999, CANCER RES, V59, P4555
   Agus DB, 1997, J CLIN INVEST, V100, P2842, DOI 10.1172/JCI119832
   Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476
   BODE AM, 1990, CLIN CHEM, V36, P1807
   BOWERSKOMRO DM, 1991, J NUTR, V121, P57
   CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911
   Carr AC, 1999, AM J CLIN NUTR, V69, P1086
   Castro M, 2001, J NEUROCHEM, V78, P815, DOI 10.1046/j.1471-4159.2001.00461.x
   DILIBERTO EJ, 1983, J BIOL CHEM, V258, P2886
   DIMATTIO J, 1989, EXP EYE RES, V49, P873, DOI 10.1016/S0014-4835(89)80046-6
   FRANCESCHI RT, 1995, AM J PHYSIOL-CELL PH, V268, pC1430
   Guaiquil VH, 1997, J BIOL CHEM, V272, P9915
   HELBIG H, 1989, AM J PHYSIOL, V256, pC44
   HODGES RE, 1971, AM J CLIN NUTR, V24, P432
   Jones SA, 1996, AM J PHYSIOL-HEART C, V271, pH1626
   KHATAMI M, 1986, INVEST OPHTH VIS SCI, V27, P1665
   Koshiishi I, 1998, BBA-GEN SUBJECTS, V1379, P257, DOI 10.1016/S0304-4165(97)00106-2
   Koshiishi I, 1998, BBA-GEN SUBJECTS, V1425, P209, DOI 10.1016/S0304-4165(98)00073-7
   Koshiishi I, 1998, CLIN CHEM, V44, P863
   Laggner T, 2000, BIOCHEM J, V345, P195
   Marumo T, 1997, CIRCULATION, V96, P2361
   MAY JM, 1995, BIOCHEMISTRY-US, V34, P12721, DOI 10.1021/bi00039a031
   MCPHAIL LC, 1992, GRANULOCYTE RESPONSE, P47
   Mendiratta S, 1998, FREE RADICAL BIO MED, V24, P789, DOI 10.1016/S0891-5849(97)00351-1
   Montecinos VP, 2000, J PHYSIOL-LONDON, V529, P777, DOI 10.1111/j.1469-7793.2000.00777.x
   Ness AR, 1996, J HYPERTENS, V14, P503
   Nishikawa T, 2000, NATURE, V404, P787
   Pagano PJ, 1997, P NATL ACAD SCI USA, V94, P14483, DOI 10.1073/pnas.94.26.14483
   PATTERSON LT, 1982, LIFE SCI, V31, P2783, DOI 10.1016/0024-3205(82)90725-1
   Qutob S, 1998, ENDOCRINOLOGY, V139, P51, DOI 10.1210/en.139.1.51
   Rivas CI, 1997, J BIOL CHEM, V272, P5814, DOI 10.1074/jbc.272.9.5814
   ROSE RC, 1988, BIOCHIM BIOPHYS ACTA, V947, P335, DOI 10.1016/0304-4157(88)90014-7
   Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982
   Sargeant LA, 2000, DIABETES CARE, V23, P726, DOI 10.2337/diacare.23.6.726
   Siushansian R, 1997, J NEUROCHEM, V68, P2378
   SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409
   Spielholz C, 1997, CANCER RES, V57, P2529
   STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305
   TOMONAGA M, 1986, BLOOD, V67, P1433
   Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986
   VERA JC, 1994, BLOOD, V84, P1628
   Vera JC, 1998, BLOOD, V91, P2536, DOI 10.1182/blood.V91.7.2536.2536_2536_2546
   VERA JC, 1995, J BIOL CHEM, V270, P23706, DOI 10.1074/jbc.270.40.23706
   VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0
   Wang HP, 1999, BBA-BIOMEMBRANES, V1461, P1, DOI 10.1016/S0005-2736(99)00182-0
   Wang YH, 1997, P NATL ACAD SCI USA, V94, P13816, DOI 10.1073/pnas.94.25.13816
   Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929
   WASHKO PW, 1993, J BIOL CHEM, V268, P15531
   WILSON JX, 1989, J MEMBRANE BIOL, V111, P83, DOI 10.1007/BF01869211
   WINKLER BS, 1987, BIOCHIM BIOPHYS ACTA, V925, P258, DOI 10.1016/0304-4165(87)90190-5
   Young VR, 1996, P NATL ACAD SCI USA, V93, P14344, DOI 10.1073/pnas.93.25.14344
   ZamoraLeon SP, 1996, P NATL ACAD SCI USA, V93, P1847, DOI 10.1073/pnas.93.5.1847
NR 52
TC 98
Z9 100
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 21
PY 2003
VL 278
IS 12
BP 10128
EP 10133
DI 10.1074/jbc.M210686200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 659LE
UT WOS:000181777500020
PM 12435736
OA Bronze
DA 2020-11-24
ER

EF